US 10,071,192 B2Grant
Catheter pump assembly including a stator
Issue Date:2018-09-11
•5 Claims
•27 Drawing Sheets
Abstract
A catheter pump assembly is provided that includes a proximal a distal portion, a catheter body, an impeller, and a flow modifying structure. The catheter body has a lumen that extends along a longitudinal axis between the proximal and distal portions. The impeller is disposed at the distal portion. The impeller includes a blade with a trailing edge. The flow modifying structure is disposed downstream of the impeller. The flow modifying structure has a plurality of blades having a leading edge substantially parallel to and in close proximity to the trailing edge of the blade of the impeller and an expanse extending downstream from the leading edge. In some embodiments, the expanse has a first region with higher curvature and a second region with lower curvature. The first region is between the leading edge and the second region.
Metadata
Assignee
- TC1 LLP
Inventor
- Zijing Zeng
Application Information
Application Number:US 15/458,279
Filing Date:2017-03-14
Priority Date:2013-03-15
Art Unit:3762
Classifications
IPC:
A61N1/362A61M1/10A61M25/00
Field of Search:
A61M 1/1008A61M 1/1024A61M 1/1031A61M 1/1034A61M 25/0082
Patent Drawings (27 sheets)
Description
BACKGROUND OF THE INVENTION
Field of the Invention
[0001] This application is directed to pumps for mechanical circulatory support of a heart. In particular, this application is directed to various implementations of a stator that can be used to enhance flow and/or performance of a catheter pump.
Description of the Related Art
[0002] Heart disease is a major health problem that has high mortality rate. Physicians increasingly use mechanical circulatory support systems for treating heart failure. The treatment of acute heart failure requires a device that can provide support to the patient quickly. Physicians desire treatment options that can be deployed quickly and minimally-invasively.
[0003] Intra-aortic balloon pumps (IABP) are currently the most common type of circulatory support devices for treating acute heart failure. IABPs are commonly used to treat heart failure, such as to stabilize a patient after cardiogenic shock, during treatment of acute myocardial infarction (MI) or decompensated heart failure, or to support a patient during high risk percutaneous coronary intervention (PCI). Circulatory support systems may be used alone or with pharmacological treatment.
[0004] In a conventional approach, an IABP is positioned in the aorta and actuated in a counterpulsation fashion to provide partial support to the circulatory system. More recently minimally-invasive rotary blood pump have been developed in an attempt to increase the level of potential support (i.e. higher flow). A rotary blood pump is typically inserted into the body and connected to the cardiovascular system, for example, to the left ventricle and the ascending aorta to assist the pumping function of the heart. Other known applications pumping venous blood from the right ventricle to the pulmonary artery for support of the right side of the heart. An aim of acute circulatory support devices is to reduce the load on the heart muscle for a period of time, to stabilize the patient prior to heart transplant or for continuing support.
[0005] There is a need for improved mechanical circulatory support devices for treating acute heart failure. Fixed cross-section ventricular assist devices designed to provide near full heart flow rate are either too large to be advanced percutaneously (e.g., through the femoral artery without a cutdown) or provide insufficient flow.
[0006] There is a need for a pump with improved performance and clinical outcomes. There is a need for a pump that can provide elevated flow rates with reduced risk of hemolysis and thrombosis. There is a need for a pump that can be inserted minimally-invasively and provide sufficient flow rates for various indications while reducing the risk of major adverse events. In one aspect, there is a need for a heart pump that can be placed minimally-invasively, for example, through a 15FR or 12FR incision. In one aspect, there is a need for a heart pump that can provide an average flow rate of 4 Lpm or more during operation, for example, at 62 mmHg of head pressure. While the flow rate of a rotary pump can be increased by rotating the impeller faster, higher rotational speeds are known to increase the risk of hemolysis, which can lead to adverse outcomes and in some cases death. Accordingly, in one aspect, there is a need for a pump that can provide sufficient flow at significantly reduced rotational speeds. These and other problems are overcome by the inventions described herein.
SUMMARY OF THE INVENTION
[0007] There is an urgent need for a pumping device that can be inserted percutaneously and also provide full cardiac rate flows of the left, right, or both the left and right sides of the heart when called for.
[0008] In one embodiment, a catheter pump assembly is provided that includes a proximal a distal portion, a catheter body, an impeller, and a flow modifying structure. The catheter body has a lumen that extends along a longitudinal axis between the proximal and distal portions. The impeller is disposed at the distal portion. The impeller includes a blade with a trailing edge. The flow modifying structure is disposed downstream of the impeller. The flow modifying structure has a plurality of blades having a leading edge substantially parallel to and in close proximity to the trailing edge of the blade of the impeller and an expanse extending downstream from the leading edge.
[0009] In some embodiments, the expanse has a first region with higher curvature and a second region with lower curvature. The first region is between the leading edge and the second region.
[0010] In some embodiments, the flow modifying structure is collapsible from a deployed configuration to a collapsed configuration.
[0011] In another embodiment, a catheter pump is provided that has an impeller and a stator. The impeller is disposed at a distal portion of the pump. The stator is disposed downstream of the impeller. The impeller is sized and shaped to be inserted into a vascular system of a patient through a percutaneous access site having a size less than about 21 FR. The catheter pump is configured to pump blood in the vascular system at physiological rates at speeds less than 25K RPM.
[0012] In another embodiment, a catheter pump assembly is provided that includes a proximal portion, a distal portion, a catheter body, and an impeller. The catheter body has a lumen that extends along a longitudinal axis between the proximal and distal portions. The impeller is disposed at the distal portion. The impeller includes a blade with a high angle to the longitudinal axis of the pump. The catheter pump assembly includes a flow modifying structure disposed downstream of the impeller. The flow modifying structure has a plurality of blades. The blades have a trailing edge that are inclined relative to a transverse plane intersecting the trailing edge. The flow modifying structure is collapsible from a deployed configuration to a collapsed configuration.
[0013] In some embodiment, the trailing edge of the impeller and the leading edge of the flow modifying structure are configured to minimize losses therebetween. For example, the gap between these structures can be maintained small to minimize turbulence at this boundary. Also, the angles of both structures to the longitudinal axis of the impeller and flow directing structure can be approximately the same, e.g., more than 60 degrees and in some cases approximately 90 degrees. The impeller includes a blade with a trailing edge at an angle of more than about 60 degrees to the longitudinal axis of the impeller.
[0014] In one embodiment, an impeller for a pump is disclosed. The impeller can comprise a hub having a proximal end portion and a distal end portion. A blade can be supported by the hub. The blade can have a fixed end coupled to the hub and a free end. Further, the impeller can have a stored configuration when the impeller is at rest, a deployed configuration when the impeller is at rest, and an operational configuration when the impeller rotates. The blade in the deployed and operational configurations can extend away from the hub. The blade in the stored configuration can be compressed against the hub. The blade can include a curved surface having a radius of curvature. The radius of curvature can be larger in the operational configuration than when the impeller is in the deployed configuration. The impeller can be used alone or in combination with a flow modifying device as discussed herein.
[0015] In another embodiment, a percutaneous heart pump is disclosed. The pump can comprise a catheter body and an impeller coupled to a distal end portion of the catheter body. The impeller can comprise a hub. A blade can be supported by the hub and can have a front end portion and a back end portion. The blade can include a ramped surface at the back end portion. A sheath can be disposed about the catheter body and can have a proximal end and a distal end. The distal end of the sheath can be configured to compress the blade from an expanded configuration to a stored configuration when the distal end of the sheath is urged against the ramped surface of the blade. In some variants, a flow modifying device is downstream of the impeller. In such variants, the ramped surface may be positioned on the flow modifying device or may be positioned on both the flow modifying device and the impeller.
[0016] In yet another embodiment, a method for storing an impeller is disclosed. The method can comprise urging a sheath against a ramped surface of a back end of a blade of an impeller. In some variants, a flow modifying structure is provided that may be distal or proximal of the impeller. If the flow modifying structure is proximal of the impeller, the method can comprise urging a sheath against a ramped surface of a back end of a blade of the flow modifying structure. The impeller can have one or more blades. Further, the impeller can have a stored configuration and a deployed configuration. Each blade in the stored configuration can be compressed against a hub of the impeller. Each blade in the deployed configuration can extend away from the hub. The method can further comprise collapsing the blade against the hub to urge the impeller into the stored configuration.
[0017] In another embodiment, a percutaneous heart pump system is disclosed. The system can comprise an impeller disposed at a distal portion of the system. The impeller can be sized and shaped to be inserted through a vascular system of a patient. The impeller can be configured to pump blood through at least a portion of the vascular system at a flow rate of at least about 3.5 liters per minute when the impeller is rotated at a speed less than about 21,000 revolutions per minute. In some cases, the percutaneous heart pump system can also have a flow modifying structure, e.g., a stator.
[0018] In another embodiment, a method of pumping blood through the vascular system of a patient is disclosed. The method can comprise inserting an impeller, with or without a flow modifying structure such as a stator, through a portion of the vascular system of the patient to a heart chamber. The method can further include rotating the impeller at a speed less than about 21,000 revolutions per minute to pump blood through at least a portion of the vascular system at a flow rate of at least about 3.5 liters per minute.
[0019] In yet another embodiment, an impeller configured for use in a catheter pump is provided. The impeller can comprise a hub having a distal portion, a proximal portion, and a diameter. The impeller can also include a blade having a fixed end at the hub and a free end. The blade can have a height defined by a maximum distance between the hub and the free end. A value relating to a ratio of the blade height to the hub diameter can be in a range of about 0.7 to about 1.45.
[0020] In another embodiment, a percutaneous heart pump system is provided. The system can comprise an impeller disposed at a distal portion of the system, the impeller sized and shaped to be inserted into a vascular system of a patient through a percutaneous access site having a size less than about 21 FR. The impeller can be configured to pump blood in the vascular system at a flow rate of at least about 3.5 liters per minute. In some variations, the heart pump system includes a flow modifying structure, such as a stator.
[0021] In another embodiment, a percutaneous heart pump system is disclosed. The system can include an impeller comprising one or more blades in a single row. The impeller can be disposed at a distal portion of the system. The impeller can be sized and shaped to be inserted through a vascular system of a patient. The impeller can be configured to pump blood through at least a portion of the vascular system at a flow rate of at least about 2.0 liters per minute when the impeller is rotated at a speed less than about 21,000 revolutions per minute. In some variations, the heart pump system includes a flow modifying structure, such as a stator.
BRIEF DESCRIPTION OF THE DRAWINGS
[0022] A more complete appreciation of the subject matter of this application and the various advantages thereof can be realized by reference to the following detailed description, in which reference is made to the accompanying drawings in which:
[0023] FIG. 1 illustrates one embodiment of a catheter pump configured for percutaneous application and operation;
[0024] FIG. 2 is a plan view of one embodiment of a catheter adapted to be used with the catheter pump of FIG. 1 ;
[0025] FIGS. 3A-3C illustrate the relative position of an impeller blade and an inner surface of an impeller housing in an undeflected configuration;
[0026] FIG. 4 shows the catheter assembly similar to that of FIG. 2 in position within the anatomy;
[0027] FIGS. 5A-5F are three-dimensional (3D) perspective views of an impeller according to one embodiment;
[0028] FIG. 6 is a 3D perspective view of an impeller according to another embodiment;
[0029] FIG. 7 is a 3D perspective view of an impeller according to yet another embodiment;
[0030] FIG. 8 is a side view of an impeller according to another embodiment;
[0031] FIGS. 9A-9E are side views of impellers according to various embodiments;
[0032] FIG. 10A is a side view of an impeller according to yet another embodiment;
[0033] FIG. 10B is a 3D perspective view of the impeller of FIG. 10A ;
[0034] FIG. 11 is a side view of an impeller according to another embodiment.
[0035] FIG. 12 is a schematic, side cross-sectional view of an impeller having a hub and one or more blades disposed within a housing.
[0036] FIG. 13 is a chart plotting flow rate versus motor speed for the impellers illustrated in FIGS. 10A-10B and 9E .
[0037] FIG. 14 is a chart plotting flow rate versus motor speed for the impeller of FIGS. 10A-10B at a given pressure, as compared to various conventional microaxial, rotary pumps at the same or similar pressure.
[0038] FIG. 14A is an H-Q curve relating to four catheter pumps.
[0039] FIG. 15 is a plan view of a distal portion of a catheter pump assembly.
[0040] FIG. 16 is perspective view of a stator assembly.
[0041] FIG. 17 is a first side view of a stator assembly.
[0042] FIG. 18 is a second side view of a stator assembly.
[0043] FIG. 19 is an end view of a stator assembly.
[0044] More detailed descriptions of various embodiments of components for heart pumps useful to treat patients experiencing cardiac stress, including acute heart failure, are set forth below.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT
[0045] This application is directed to apparatuses for inducing motion of a fluid relative to the apparatus. In particular, the disclosed embodiments generally relate to various configurations for an impeller disposed at a distal portion of a percutaneous catheter pump. For example, FIGS. 1-4 show aspects of an exemplary catheter pump 10 that can provide high performance flow rates. The exemplary pump 10 includes a motor driven by a controller 22. The controller 22 directs the operation of the motor 14 and an infusion system 26 that supplies a flow of infusate in the pump 10. A catheter system 80 that can be coupled with the motor 14 houses an impeller within a distal portion thereof. In various embodiments, the impeller is rotated remotely by the motor 14 when the pump 10 is operating. For example, the motor 14 can be disposed outside the patient. In some embodiments, the motor 14 is separate from the controller 22, e.g., to be placed closer to the patient. In other embodiments, the motor 14 is part of the controller 22. In still other embodiments, the motor is miniaturized to be insertable into the patient. Such embodiments allow the drive shaft to be much shorter, e.g., shorter than the distance from the aortic valve to the aortic arch (about 5 cm or less). Some examples of miniaturized motors catheter pumps and related components and methods are discussed in U.S. Pat. No. 5,964,694; U.S. Pat. No. 6,007,478; U.S. Pat. No. 6,178,922; and U.S. Pat. No. 6,176,848, all of which are hereby incorporated by reference herein in their entirety for all purposes.
[0046] FIG. 4 illustrates one use of the exemplary catheter pump 10. A distal portion of the pump 10, which can include an impeller assembly 92, is placed in the left ventricle (LV) of the heart to pump blood from the LV into the aorta. The pump 10 can be used in this way to treat patients with a wide range of conditions, including cardiogenic shock, myocardial infarction, and other cardiac conditions, and also to support a patient during a procedure such as percutaneous coronary intervention. One convenient manner of placement of the distal portion of the pump 10 in the heart is by percutaneous access and delivery using the Seldinger technique or other methods familiar to cardiologists. These approaches enable the pump 10 to be used in emergency medicine, a catheter lab and in other non-surgical settings. Modifications can also enable the pump 10 to support the right side of the heart. Example modifications that could be used for right side support include providing delivery features and/or shaping a distal portion that is to be placed through at least one heart valve from the venous side, such as is discussed in U.S. Pat. No. 6,544,216; U.S. Pat. No. 7,070,555; and US 2012-0203056A1, all of which are hereby incorporated by reference herein in their entirety for all purposes.
[0047] FIG. 2 shows features that facilitate small blood vessel percutaneous delivery and high performance, including up to and in some cases exceeding normal cardiac output in all phases of the cardiac cycle. In particular, the catheter system 80 includes a catheter body 84 and a sheath assembly 88. The impeller assembly 92 is coupled with the distal end of the catheter body 84. The exemplary impeller assembly 92 is expandable and collapsible. In the collapsed state, the distal end of the catheter system 80 can be advanced to the heart, for example, through an artery. In the expanded state, the impeller assembly 92 is able to pump blood at high flow rates. FIGS. 2-4 illustrate the expanded state. The collapsed state can be provided by advancing a distal end 94 of an elongate body 96 distally over the impeller assembly 92 to cause the impeller assembly 92 to collapse. This provides an outer profile throughout the catheter assembly 80 that is of small diameter, for example, to a catheter size of about 12.5 FR in various arrangements. Although various expandable impellers are disclosed herein (e.g., impellers having a stored configuration and a deployed configuration), it should be appreciated that the principles described below may also be applicable to impellers that may not be expandable or collapsible. For example, the impeller parameters described herein may also be applicable to fixed diameter impellers in some arrangements.
[0048] In some embodiments, the impeller assembly 92 includes a self-expanding material that facilitates expansion. The catheter body 84 on the other hand preferably is a polymeric body that has high flexibility. When the impeller assembly 92 is collapsed, as discussed above, high forces are applied to the impeller assembly 92. These forces are concentrated at a connection zone, where the impeller assembly 92 and the catheter body 84 are coupled together. These high forces, if not carefully managed can result in damage to the catheter assembly 80 and in some cases render the impeller within the impeller assembly 92 inoperable. Robust mechanical interface, are provided to assure high performance.
[0049] The mechanical components rotatably supporting the impeller within the impeller assembly 92 permit high rotational speeds while controlling heat and particle generation that can come with high speeds. The infusion system 26 delivers a cooling and lubricating solution to the distal portion of the catheter system 80 for these purposes. However, the space for delivery of this fluid is extremely limited. Some of the space is also used for return of the infusate. Providing secure connection and reliable routing of infusate into and out of the catheter assembly 80 is critical and challenging in view of the small profile of the catheter body 84.
[0050] When activated, the pump 10 can effectively increase the flow of blood out of the heart and through the patient's vascular system. In various embodiments disclosed herein, the pump 10 can be configured to produce a maximum flow rate (e.g. low mm Hg) of greater than 4 Lpm, greater than 4.5 Lpm, greater than 5 Lpm, greater than 5.5 Lpm, greater than 6 Lpm, greater than 6.5 Lpm, greater than 7 Lpm, greater than 7.5 Lpm, greater than 8 Lpm, greater than 9 Lpm, or greater than 10 Lpm. In various embodiments, the pump can be configured to produce an average flow rate at about 62 mmHg during operation of greater than 2 Lpm, greater than 2.5 Lpm, greater than 3 Lpm, greater than 3.5 Lpm, greater than 4 Lpm, greater than 4.5 Lpm, greater than 5 Lpm, greater than 5.5 Lpm, or greater than 6 Lpm. In various embodiments, the pump can be configured to produce an average flow rate of at least about 4.25 Lpm at 62 mmHg. In various embodiments, the pump can be configured to produce an average flow rate of at least about 4 Lpm at 62 mmHg. In various embodiments, the pump can be configured to produce an average flow rate of at least about 4.5 Lpm at 62 mmHg. Flow modifying structures, such as fins or blades, which can be implemented in a stator, can be provided higher peak flow rate output by the pump 10 as discussed below.
[0051] Various aspects of the pump and associated components are similar to those disclosed in U.S. Pat. Nos. 7,393,181, 8,376,707, 7,841,976, 7,022,100, and 7,998,054 and U.S. Pub. Nos. 2011/0004046, 2012/0178986, 2012/0172655, 2012/0178985, and 2012/0004495, the entire contents of which are incorporated herein for all purposes by reference. In addition, this application incorporates by reference in its entirety and for all purposes the subject matter disclosed in each of the following concurrently filed applications: application Ser. No. 13/802,556, entitled “DISTAL BEARING SUPPORT,” filed on Mar. 13, 2013; Application No. 61/780,656, entitled “FLUID HANDLING SYSTEM,” filed on Mar. 13, 2013; application Ser. No. 13/801,833, entitled “SHEATH SYSTEM FOR CATHETER PUMP,” filed on Mar. 13, 2013; application Ser. No. 13/801,528, entitled “CATHETER PUMP,” filed on Mar. 13, 2013; and application Ser. No. 13/802,468, entitled “MOTOR ASSEMBLY FOR CATHETER PUMP,” filed on Mar. 13, 2013.
Blade & Impeller Configurations
[0052] With reference to FIGS. 3A-3C , an operative device of the pump can include an impeller 300 having one or more blades 303. The one or more blades 303 can extend from an impeller hub 301. It can be desirable to increase the flow rate of the heart pump while ensuring that the impeller 300 can be effectively deployed within a subject. For example, an impeller can include one or more blades 303 that are configured to be inserted into a subject in a stored, or compressed, configuration. When the impeller 300 is positioned in the desired location, e.g., a chamber of a subject's heart as shown in FIG. 4 , the blade(s) 303 of the impeller 300 can self-expand into a deployed or expanded configuration, in which the blade(s) 303 extends radially from a hub 301.
[0053] As shown in FIGS. 3A-3B , the impeller 300 can be positioned within a cannula or housing 202. A free end of the blades 303 can be separated from the wall W of the housing 202 by a tip gap G. The housing 202 can also have a stored, or compressed configuration, and a deployed or expanded configuration. The housing 202 and impeller 300 may deploy from the stored configurations from within a sheath or sleeve (not shown) into the expanded configuration. In such implementations, the sheath or sleeve can keep the blade(s) 303 and the housing 202 compressed until the blade(s) 303 and housing 202 are urged from within a storage cavity of the sheath or sleeve. Once the blade(s) 303 are released from the storage cavity of the sheath, the blade(s) 303 can self-expand to a deployed configuration using strain energy stored in the blades 303 due to deformation of the blade(s) 303 within the sheath or sleeve. The expandable housing 202 may also self-deploy using stored strain energy after being urged from the sheath.
[0054] In the stored configuration, the impeller 300 and housing 202 have a diameter that is preferably small enough to be inserted percutaneously into a patient's vascular system. Thus, it can be advantageous to fold the impeller 300 and housing 202 into a small enough stored configuration such that the housing 202 and impeller 300 can fit within the patient's veins or arteries. In some embodiments, therefore, the impeller 300 can have a diameter in the stored configuration corresponding to a catheter size between about 8 FR and about 21 FR. In one implementation, the impeller 300 can have a diameter in the stored state corresponding to a catheter size of about 9 FR. In other embodiments, the impeller 300 can have a diameter in the stored configuration between about 12 FR and about 21 FR. For example, in one embodiment, the impeller 300 can have a diameter in the stored configuration corresponding to a catheter size of about 12 FR or about 12.5 FR.
[0055] When the impeller 300 is positioned within a chamber of the heart, however, it can be advantageous to expand the impeller 300 to have a diameter as large as possible in the expanded or deployed configuration. In general, increased diameter of the impeller 300 can advantageously increase flow rate through the pump. In some implementations, the impeller 300 can have a diameter corresponding to a catheter size greater than about 12 FR in the deployed configuration. In other embodiments, the impeller 300 can have a diameter corresponding to a catheter size greater than about 21 FR in the deployed or expanded configuration.
[0056] In various embodiments, it can be important to increase the flow rate of the heart pump while ensuring that the operation of the pump does not harm the subject. For example, increased flow rate of the heart pump can advantageously yield better outcomes for a patient by improving the circulation of blood within the patient. Furthermore, the pump should avoid damaging the subject. For example, if the pump induces excessive shear stresses on the blood and fluid flowing through the pump (e.g., flowing through the cannula), then the impeller can cause damage to blood cells, e.g., hemolysis. If the impeller damages a large number of blood cells, then hemolysis can lead to negative outcomes for the subject, or even death. As will be explained below, various blade parameters can affect the pump's flow rate as well as conditions within the subject's body. Also, flow modifying structures such as stationary fins or blades, e.g., as part of a stator, can enhance the performance and/or efficiency of the pump 10. In some arrangements, a stator may change the direction of flow, e.g., from a substantial portion circumferential to primarily axial direction. In some arrangements, the stator may modify the flow, e.g., to realign a complex flow field into a more uniform, laminar flow. This is sometimes referred to as smoothing out the flow or reducing turbulence. In this case, the stator may also serve to convert the kinetic energy of the complex flow field in the region of the trailing edges of the impeller into pressure before it is directed back into the circulatory system. This has been found to improve hydraulic efficiency because the complex, rotational flow field energy would normally be dissipated in the pump. In some arrangements, the stator may realign and redirect the flow. These embodiments enable the pump 10 to create a greater pressure head (i.e. pressure differential) at the same rotational speed and backpressure. In turn, the clinician can advantageously adjust the pump to improve patient outcomes. The clinician can obtain a higher pressure head (H) at the same flow rate. Alternatively, the clinician may be able to obtain a higher flow rate (Q) with the same head pressure. The clinician may also be able to achieve improves to both H and Q. The pump may also be maintained the same head pressure and flow rate at a lower rotational speed. Lowering the rotational speed can reduce hemolysis risk. Thus, pump 10 demonstrates significant performance improvements compared to a pump without these structures. These improvements to performance translate into improvements in clinical outcomes and expand the range of clinical applications of the pump.
Overview of Various Embodiments
[0057] Various embodiments of an impeller for use in a heart pump are disclosed herein and the various impellers can be combined with a stator for enhanced performance as described further herein. Before discussing the combination of impellers and stators, various aspects of impeller embodiments will be discussed. In particular, FIGS. 5A-11 illustrate different configurations for an impeller 300-300J. Each of the disclosed impellers 300-300J can be defined by several different characteristics or parameters that can advantageously improve flow rate while achieving healthy outcomes in a patient. Further, various properties or characteristics of the disclosed impellers may assist in storing and/or deploying the impeller into and/or out from an outer sleeve. Each figure may only illustrate a few of the characteristics of the impeller for ease of illustration. However, it should be appreciated that each illustrated impeller may be associated with all of the characteristics or properties disclosed herein. For example, some figures may illustrate only a few angles or other geometric or structural properties of the impeller, but it should be appreciated that all the impellers disclosed herein may be associated with the disclosed characteristics or properties (see, e.g., the example values given in Tables 1 and 2).
[0058] In order to improve patient outcomes, it can be advantageous to provide a heart pump capable of pumping blood at high flow rates while minimizing damage to the blood or the patient's anatomy. For example, it can be desirable to increase flow rate while reducing the motor speed, as higher motor speeds are known to increase the hemolysis risk. Furthermore, for percutaneous insertion heart pump systems, it can be advantageous to make the diameter of the impeller and the cannula as small as possible for insertion into the patient's vasculature. Accordingly, the various impeller embodiments disclosed herein can provide high flow rate while maintaining a diameter small enough for insertion into the patient's vasculature and while reducing the risk that the patient's anatomy and blood are damaged during operation of the pump.
[0059] For the impellers 300-300J illustrated in FIGS. 5A-11 , for example, the blades 303 may be formed to have a curved profile with a radius of curvature, R. The radius of curvature R may be sized such that, when the impeller is in the stored or compressed configuration, the blades 303 conform closely to the hub 301. Indeed, in various arrangements, the blades 303 in the stored configuration can have a radius RS sized such that the blades 303 lie against the hub 301 in a low profile so that the insertion diameter of the catheter pump is small enough to be safely inserted through the patient's vasculature. In some embodiments, the radius of curvature R and/or the height h of the blade 303 are selected such that neighboring blades in a particular blade row do not overlap when the impeller is in the stored configuration. By reducing or eliminating blade overlap in the stored configuration, the insertion diameter of the catheter pump can be reduced. In other arrangements, however, neighboring blades may overlap in the stored configuration.
[0060] Furthermore, when the impeller is urged out of an external sleeve, the impeller can self-expand into a deployed configuration, in which the impeller is deployed from the sleeve and expanded into a deployed diameter larger than a stored diameter. In various embodiments, the self-expansion of the impeller can be induced by strain energy stored in the blades 303, such as strain or potential energy stored near the root of the blades 303. When the sleeve is urged away from the impeller, the blades 303 can be free to expand into the deployed configuration. It should be appreciated that when the blades 303 are in the deployed configuration, the blade(s) 303 can be in a relaxed state, such that there are no or minimal external forces (such as torque- or flow-induced loads) and internal forces (such as strain energy stored in the blades) applied to the impeller or blades. A radius of curvature RD of the blades 303 in the deployed configuration may be selected to improve flow characteristics of the pump while reducing the risk of hemolysis or other damage to the patient. For example, in some embodiments, the impeller can be molded to form blades 303 having the desired deployed radius of curvature RD, such that in a relaxed (e.g., deployed) state, the blades 303 have a radius of curvature RD that may be selected during manufacturing (e.g., molding). In some arrangements, the radius of curvature RD of the blades in the deployed configuration may be about the same as the radius of curvature RS of the blades in the stored configuration. In other arrangements, however, the radius of curvature of the blades 303 in the stored and deployed configurations may be different.
[0061] When the heart pump is activated to rotate the impeller, the impeller and blades 303 may be in an operational configuration. In the operational configuration, the impeller may rotate to drive blood through the housing 202. The rotation of the impeller and/or the flow of blood past the impeller can cause the blades 303 to deform such that an operational radius of curvature Ro may be induced when the impeller is in the operational configuration. For example, when the impeller rotates, the blades 303 may slightly elongate such that the free ends of the blades 303 extend further radially from the hub 301 relative to when the blades 303 are in the deployed configuration. As the blades 303 deform radially outward in the operational configuration, the operational radius of curvature Ro may therefore be larger than the deployed radius of curvature RD. For example, in some embodiments, in the operational configuration, the blades 303 may substantially flatten such that there is little curvature of the blades during operation of the pump. Indeed, in the operational configuration, the blades 303 may extend to an operational height ho that is larger than the height h of the blades 303 when in the deployed configuration (see h as illustrated in the impellers 300-300J of FIG. 5A-11 , which are in a deployed or relaxed configuration). In some embodiments, because the blades 303 may be manufactured to be relaxed when in the deployed configuration, the radius of curvature RD and the height h of the blades 303 in the deployed configuration can be selected such that, in the operational configuration, the blades 303 extend radially outward from the hub 301 as far as possible without risking an overly small tip gap G (see FIG. 3C ). Flow rate can be improved by enabling the blades 303 to extend radially outward to a greater extent in the operational configuration than in the deployed configuration.
[0062] It should be appreciated that the various parameters described herein may be selected to increase flow rate, even while reducing the rotational speed of the impeller. For example, even at relatively low impeller rotational rates of 21,000 revolutions per minute (RPM) or less (e.g., rates in a range of about 18,000 RPM to about 20,000 RPM, or more particularly, in a range of about 18,500 RPM to about 19,500 RPM in some arrangements), the blades 303 can be designed to yield relatively high flow rates in a range of about 4 liters/minute (LPM) to about 5 liters/minute. Conventional percutaneous rotary blood pumps have been found to deliver less than ideal flow rates even at rotational speeds in excess of 40,000 RPM. It should be appreciated that higher impeller rotational rates may be undesirable in some aspects, because the high rate of rotation, e.g., higher RPMs, lead to higher shear rates that generally increase hemolysis and lead to undesirable patient outcomes. By reducing the impeller rotational rate while maintaining or increasing flow rate, the pump in accordance with aspects of the invention can reduce the risk of hemolysis while significantly improving patient outcomes over conventional designs.
[0063] Furthermore, to enable percutaneous insertion of the operative device of the pump into the patient's vascular system, the impellers 300-300J disclosed herein in FIGS. 5A-11 may also include a ramped surface at a rearward or proximal end of the blade. As explained herein (see, e.g., FIG. 12 ), when the external sleeve is urged against the housing 202 (e.g., cannula), the external sleeve can press against the housing 202 and the ramped surface of the impeller to collapse the impeller and blades into the stored configuration. For example, the ramped surface can be used to store the blades and impeller after assembly of the pump for packaging purposes and/or after performing a heart pumping procedure for withdrawal of the pump from the anatomy.
[0064] The impellers disclosed herein may be formed of any suitable material and by any suitable process. For example, in preferred embodiments, the impeller is formed from a flexible material, e.g., an elastic material such as a polymer. Any suitable polymer can be used. In some embodiments, for example, Hapflex™ 598, Hapflex™ 798, or Steralloy™ or Thoralon™ may be used in various portions of the impeller body. In some arrangements, the impeller body can be molded to form a unitary body.
Various Impeller Designs
[0065] Turning to FIGS. 5A-5F , one embodiment of the impeller 300 is presented. It should be appreciated that FIGS. 5A-5F illustrate the same impeller 300, only showing different views and impeller parameters for ease of illustration. One or more blades 303 can extend from the hub 301, such that a fixed end of the blades 303 is integrally formed with or coupled to the hub 301. The blades 303 can also have a free end located at the tip of the blades 303. As used herein, therefore, it should be appreciated that the blades 303 can have a fixed end coupled to the hub 301 (e.g., at a blade root) and a free end at a tip of the blade 303. In the illustrated embodiments, the hub 301 and blades 303 form a single unitary, or monolithic, body. However, it should be appreciated that in other embodiments, the hub 301 and blades 303 may be formed from separate components or materials. In various implementations, the impeller 300 can include one or more blade rows extending along the hub 301.
[0066] FIGS. 5A-5F illustrate the impeller 300 having one blade row and two blades 303. The hub 301 can have a first diameter D1 at a distal end portion of the impeller 300 (e.g., near a leading edge of the blade(s) 303) and a second diameter D2 at a proximal end portion of the impeller 300 (e.g., near a trailing edge of the blade(s) 303). As used herein and as shown in FIG. 5A , for example, a distal end portion of the impeller 300 may be disposed nearer the distal end of the catheter pump, while a proximal end portion of the impeller 300 may be disposed nearer the motor and the insertion site. As explained below, in some implementations, D1 can be less than D2. The hub 301 can also have a length L, and the blades 303 can have a height h, which can be the distance between the hub and the free end of the blades. Further, each blade 303 can have a blade length Lb, which may or may not be the same as the hub length L. As shown in FIG. 5A , the height h may be measured from the hub 301 to the free end of a middle portion of the blades 303 when the impeller is in a deployed or relaxed configuration. The height h may vary along the length of the blades 303, e.g., increasing proximally from a forward or distal end of the blades 303 to a maximum in a middle portion of the blades and decreasing from the middle portion to a rearward or proximal portion of the blades. Furthermore, as explained above, when the impeller 300 rotates and is in an operational configuration, the operational height ho may be larger than the blade height h in the deployed or relaxed configuration, which is illustrated in FIGS. 5A-5F .
[0067] Furthermore, each blade 303 can include a suction side 305 and a pressure side 307. In general, fluid can flow from the suction side 305 of the blade 303 toward the pressure side 307 of the blade 303, e.g., from the distal end portion of the impeller 300 to the proximal end portion of the impeller 300. The pressure side 307 can be include a curved, concave surface having a predetermined radius of curvature R, as best seen in FIG. 5C , and as explained above. For example, in FIGS. 5A-5F , the illustrated radius of curvature R corresponds to a relaxed or deployed radius of curvature RD. As explained above, when the impeller 300 rotates, the impeller may be in an operational configuration having an operational radius of curvature Ro that may be larger than the deployed radius of curvature RD. Indeed, in some embodiments, the blades 303 may substantially flatten and elongate radially such that there is little curvature. The elongated blades 303 in the operational configuration may enable for increased flow rate through the pump.
[0068] Moreover, each blade 303 can have a thickness designed to improve impeller performance. As shown in FIG. 5B , the leading edge or distal end portion of the blade 303 can have a first thickness t1a at the fixed end of the blade 303, where the blade 303 joins the hub 301, and a second thickness t1b at the free end of the blade 303. Similarly, in FIG. 5C , the trailing edge of the blade 303 can also have a first thickness t2a at the fixed end of the blade 303 and a second thickness t2b at the free end of the blade 303. Example parameters for various blades in FIGS. 5A-11 will be disclosed in the description below and in Tables 1 and 2.
[0069] Each blade 303 can wrap around the hub 301 by a desired wrapping angle. The wrapping angle can be measured along the circumference of the hub 301. As shown in the illustrated embodiments, each blade 303 can separately track a helical pattern along the surface of the hub 301 as the blade 303 wraps around the hub 301 along the length L of the hub. Table 2 and the disclosure below illustrate example wrapping angles for blades 303 in various embodiments. The blades can wrap around the hub any suitable number of turns or fractions thereof. Further, a first fillet 311 can be formed at the fixed end of each blade on the suction side 305, and a second fillet 313 can be formed at the fixed end of each blade 303 on the pressure side 307. As shown each fillet 311, 313 can follow the fixed end of each blade 303 as it wraps around the hub 301. As explained below, the first fillet 311 can be sized and shaped to provide support to the blade 303 as the impeller 300 rotates. The second fillet 313 can be sized and shaped to assist in folding or compressing the blade 303 into the stored configuration.
[0070] In addition, each blade 303 can form various blade angles α, β, and γ. As shown in FIGS. 5D-F , the blade angles α (referred to herein as an “attack angle α” or a “distal blade angle α”), β (referred to herein as a “middle blade angle β”), and γ (referred to herein as a “proximal blade angle γ”) measure the angles between a blade centerline at various portions of the blade and a plane that is perpendicular to the hub 301. For example, the attack angle α can measure the angle between a plane formed perpendicular to the blade near the distal portion of the blade (e.g., distally along the impeller hub in FIG. 5D ) and a plane formed perpendicular to the hub 301. The attack angle α can range between about 30 degrees and about 60 degrees. In some implementations, α can range between about 40 degrees and about 55 degrees. In the implementation of FIG. 5D , for example, a can be in a range of about 48 degrees and about 52 degrees, e.g., about 50 degrees. The middle blade angle β can measure the angle between a plane perpendicular to the blade in a middle portion of the blade and a plane perpendicular to the hub 301. In some implementations, β can range from about 30 degrees to about 45 degrees. In the implementations of FIGS. 5A-5F and 6 , for example, β can be in a range of about 35 degrees and about 42 degrees, e.g., about 40 degrees. The proximal blade angle γ can correspond to the angle between a plane perpendicular to the blade in a proximal portion of the blade (e.g., proximal with respect to the hub 301) and a plane perpendicular to the hub 301. In some embodiments, γ can range between about 25 degrees and about 55 degrees. In the illustrated embodiment of FIG. 5F , γ can be in a range of about 30 degrees and about 40 degrees, or about 35 degrees, for example. In some embodiments, the attack angle α can be larger than the middle blade angle β. Further, in some embodiments, the middle blade angle can be larger than the proximal blade angle γ. In some embodiments, the attack angle α can be larger than both the middle blade angle β and the proximal blade angle γ. The blade angles α, β, and γ can be further designed using computational techniques to maintain desired flow characteristics, such as flow rate, pressure head, and rotational speed. For example, the disclosed blade angles can, in various impellers disclosed herein, enable flow rates in a range of about 4 liters/minute to about 5.5 liters/minute, when the impeller rotates at a speed below about 20,000 RPMs (e.g., in a range of about 19,000 RPMs to about 21,000 RPMs in some arrangements). By maintaining a high flow rate at relatively low rotational speeds, the disclosed impellers can achieve desirable patient outcomes while reducing the risk of hemolysis and increasing pump reliability.
[0071] Further, the trailing edge of each blade 303 can include a ramp 315 forming a ramp angle θ with the plane perpendicular to the hub 301, as best illustrated in FIG. 5C . The ramp 315 can be shaped such that when the sheath and housing 202 are urged against the ramp 315, or when the blades 303 and housing 202 are pulled proximally relative to and into the sheath, the axial force applied by the sheath can be transferred downward by the ramp 315 to assist in folding the blade 303 against the hub 301. The ramp angle θ can be configured to assist in folding the blade 303 against the hub 301. Further, the cross-sectional curvature and/or axial form of the blades can also be configured to reduce the force needed to collapse the impeller when used in conjunction with the ramp angle θ. For example, the angle that the blades twist around the hub may be configured to direct axial forces applied by the sheath to fold the blades against the hub 301. The radius of curvature R of the blades 303 can also be selected to enable the blades 303 to conform closely to the hub 301, as explained above.
[0072] Turning to FIGS. 6-11 , other embodiments of the impeller 300 are illustrated. Reference numerals in FIGS. 6-11 generally represent components similar to those of FIGS. 5A-5F . In addition, it should be appreciated that the parameters and angles described above with reference to FIGS. 5A-5F are also present in the impellers disclosed in FIGS. 6-11 , even where such parameters or angles are not specifically referenced for ease of illustration. For example, FIG. 6 illustrates an impeller 300A having two blades 303 in one blade row. On the other hand, FIG. 7 illustrates an impeller 300B having three blades 303 in a single blade row. FIG. 8 illustrates another example of an impeller 300C having two blades 303 in one blade row. FIGS. 9A-9C illustrate three impellers 300F-300H, respectively, each having two blades in one row. FIG. 9D illustrates an impeller 3001 having three blades in one row. By contrast, FIG. 9E shows an impeller 300J having four blades total, with two blade rows, each blade row having two blades. FIGS. 10A-10B illustrate yet another impeller 300D having three blades 303 in a single row, while FIG. 11 shows an impeller 300E having two blades 303 in a single row. Tables 1 and 2 include various properties for the impellers 300 shown in the embodiments of FIGS. 5A-5C and 6-11 . The impellers 300-300J disclosed herein may have different values for the various parameters and characteristics disclosed herein, and some of the impellers may have improved performance relative to other of the disclosed impellers.
[0073] The impellers 300 illustrated in the disclosed embodiments may have other features. For example, for impellers with multiple blade rows, the blade(s) in one row may be angularly clocked relative to the blade(s) in another row. It should be appreciated that the blades may be configured in any suitable shape or may be wrapped around the impeller hub in any manner suitable for operation in a catheter pump system.
Impeller Parameters
[0074] As explained above, various impeller parameters can be important in increasing flow rate while ensuring that the pump operates safely within the subject. Further, various properties and parameters of the disclosed impellers 300-300J of FIGS. 5A-11 may enable the impellers to more easily collapse into the stored configuration. Similarly, with regard to FIGS. 15-19 , features of stators enhancing these and other aspects are discussed below.
Hub Diameter and Length
[0075] One impeller parameter is the size of the hub, e.g., the diameter and/or the length of the hub. As illustrated in FIGS. 5A-11 , the hub can be tapered in various embodiments, such that the distal end portion of the hub has a first diameter, D1, and the proximal end portion of the hub has a second diameter, D2. The first and second diameters, D1 and D2 can determine the spacing between the wall W of the housing 202 and the hub 301. Since the housing 202 effectively bounds the area through which blood can flow, the spacing between the hub 301 and the housing wall W may determine the maximum flow rate through the pump. For example, if the hub 301 has a relatively small diameter, then the flow area between the inner wall W of the housing 202 and the hub 301 may be larger than in embodiments with a larger hub diameter. Because the flow area is larger, depending on other impeller parameters, the flow rate through the pump may advantageously be increased.
[0076] One of skill in the art will appreciate from the disclosure herein that the impeller parameters may be varied in accordance with the invention. For a known pressure, blade height, h, and impeller angular velocity, ratios of D1 to D2 can be determined to provide the desired flow rate, Q. The hub diameter can vary. In some embodiments, D1 can range between about 0.06 inches and about 0.11 inches. D2 can range between about 0.1 inches and about 0.15 inches. For example, in the impeller shown in FIGS. 5A-5F , D1 can be about 0.081 inches, and D2 can be about 0.125 inches. In the implementation of FIGS. 10A and 10B , D1 can be in a range of about 0.08 inches and about 0.09 inches (e.g., about 0.0836 inches in some arrangements), and D2 can be in a range of about 0.12 inches and about 0.13 inches (e.g., about 0.125 inches in some arrangements).
[0077] Moreover, the length, Lb, of each blade can be designed in various embodiments to achieve a desired flow rate and pressure head. In general, longer blades can have higher flow rates and pressure heads. Without being limited by theory, it is believed that longer blades can support more blade material and surface area to propel the blood through the cannula. Thus, both the length of the blades and the first and second diameters D1 and D2 can be varied to achieve optimal flow rates. For example, D1 can be made relatively small while Lb can be made relatively long to increase flow rate.
Blade Height
[0078] Another impeller parameter is the height h of the blades of the impeller in the deployed, or relaxed, configuration. The height h of the blades can be varied to achieve a stable flow field and to reduce turbulence, while ensuring adequate flow rate. For example, in some embodiments, the blade can be formed to have a height h large enough to induce adequate flow through the cannula. However, because the blades are preferably flexible so that they can fold against the hub in the stored configuration, rotation of the impeller may also cause the blades to flex radially outward due to centrifugal forces. As explained above with respect to FIGS. 3A-3C , the tip gap G between the wall W of the housing 202 and the free ends of the blades can be quite small. If the blades 303 flex outwardly by a substantial amount when the impeller 300 rotates, then the distal ends of the blades 303 may impact the housing wall W, which can damage blood cells passing by. Thus, the height h may also be formed to be sufficiently small such that, upon rotation of the impeller 300, deformation of the blades 300 still maintains adequate tip gap G.
[0079] On the other hand, as explained above, the height h of the blades 303 in the deployed configuration can be selected such that when the impeller rotates, the tip or free end of the blades 303 can extend or elongate to an operational height ho, which extends further radially than when in the deployed configuration, in order to increase flow rate. Thus, as explained herein, the height h and the radius of curvature RD of the blades 303 in the deployed configuration can be selected to both increase flow rate while reducing the risk of hemolysis caused by inadequate tip gap G.
[0080] In various implementations, the height of the blades near the middle of the impeller hub can range between about 0.06 inches and about 0.15 inches, for example, in a range of about 0.09 inches to about 0.11 inches. Of course, the height of the blades can be designed in conjunction with the design of the hub diameters and length, and with the radius of curvature R. As an example, for the impeller in FIGS. 5A-5C , the height h of the blade near the middle of the impeller hub can be in a range of about 0.09 inches and about 0.1 inches (e.g., about 0.0995 inches in some arrangements). In the impeller of FIGS. 10A-10B , the height h of the blade can be in a range of about 0.1 inches and about 0.11 inches (e.g., about 0.107 inches in some arrangements). Other example blade heights may be seen in Table 1.
Number of Blades
[0081] As mentioned above, impellers 300 can have any suitable number of blades 303. In general, in impellers with more blades 303, the flow rate of blood flowing through the cannula or housing 202 can be advantageously increased while reducing the required angular velocity of the drive shaft. Thus, absent other constraints, it can be advantageous to use as many blades as possible to maximize flow rate. However, because the impellers disclosed herein can be configured to fold against the hub 301 in the stored configuration for insertion into a patient's vasculature, using too many blades 303 can increase the overall volume of the impeller in the stored configuration. If the thickness of the impeller 300 in the stored configuration exceeds the diameter of the sheath or sleeve (or the diameter of the patient's artery or vein), then the impeller 300 may not collapse into the sheath for storing.
[0082] Moreover, increasing the number of blades 303 accordingly increases the number of shear regions at the free end of the blades 303. As the impeller 300 rotates, the free ends of the blades 303 induce shear stresses on the blood passing by the blades 303. In particular, the tip or free edge of the blades 303 can induce significant shear stresses. By increasing the overall number of blades 303, the number of regions with high shear stresses are accordingly increased, which can disadvantageously cause an increased risk of hemolysis in some situations. Thus, the number of blades can be selected such that there is adequate flow through the pump, while ensuring that the impeller 300 can still be stored within the sheath and that the blades 303 do not induce excessive shear stresses. In various arrangements, for example, an impeller having three blades (such as the impellers shown in FIGS. 7, 9D, and 10A-10B ) can achieve an appropriate balance between increased flow rate and reduced risk of hemolysis.
Radius of Curvature
[0083] Yet another design parameter for the impeller is the radius of curvature, R, of the blades 303 on the pressure side 307 of the blades, as explained in detail above. As shown in FIGS. 5A-11 , the illustrated impellers 300-300J are in the deployed configuration, such that the illustrated R corresponds to the deployed radius of curvature RD. The radius of curvature R can be designed to minimize turbulence, while increasing flow rate. Turbulence can disadvantageously dissipate energy as the impeller rotates, which can reduce the flow rate. In general, higher curvature on the pressure side 307 of the blades 303 can increase turbulence. Moreover, the radius of curvature R can be designed to conform to the hub 301 such that, when the impeller is compressed by the sheath or sleeve, the curved pressure side 307 of the blade 303 conforms to the curvature of the hub 301 when the blades 303 are folded against the hub. Thus, the radius of curvature R of the blades can be designed to both reduce turbulent flow and to assist in folding the blades against the hub to ensure that the impeller 300 fits within the sheath in the stored configuration.
[0084] In addition, as explained above, when the impeller rotates and is in the operational configuration, the free end of the blades 303 may extend radially outward such that the radius of curvature in the operational configuration, Ro, may be higher than the radius of curvature in the operational configuration, RD, which is illustrated as R in FIGS. 5A-11 . Indeed, the straightening and elongation of the blades 303 in the operational configuration may advantageously increase flow rate through the pump system.
[0085] The radius of curvature can range between about 0.06 inches and about 0.155 inches in various embodiments. In some embodiments, the radius of curvature can range between about 0.09 inches and about 0.14 inches. For example, in the implementation of FIGS. 5A-5C , the cross-sectional radius of curvature R at the leading edge of the blades can be in a range of about 0.11 inches and about 0.13 inches (e.g., about 0.12 inches in some arrangements). By comparison, the radius of curvature R of the leading edge of the blades in the impeller 300 shown in FIGS. 10A-10B (in the deployed configuration) can be in a range of about 0.13 inches to about 0.14 inches (e.g., about 0.133 inches in some arrangements). Other curvatures may be suitable in various embodiments. Table 2 illustrates example values for the radius of curvature R of various embodiments disclosed herein, when the impellers are in the deployed configuration.
Blade Thickness
[0086] In addition, the thickness of the blades 303 can be controlled in various implementations. In general, the thickness of the blades can range between about 0.005 inches and about 0.070 inches in some embodiments, for example in a range of about 0.01 inches to about 0.03 inches. It should be appreciated that the thickness can be any suitable thickness. The thickness of the blade 303 can affect how the blade 303 collapses against the hub 301 when compressed into the stored configuration and how the blade deforms when rotating in an operational configuration. For example, thin blades can deform more easily than thicker blades. Deformable blades can be advantageous when they elongate or deform by a suitable amount to increase flow rate, as explained above. However, as explained above, if the blade 303 deforms outward by an excessive amount, then the free end of the blade can disadvantageously contact the inner wall of the housing 202 when the impeller 300 rotates. On the other hand, it can be easier to fold thin blades against the hub 301 because a smaller force can sufficiently compress the blades 303. Thus, it can be important in some arrangements to design a blade sufficiently stiff such that the blade 303 does not outwardly deform into the cannula or housing 202, while still ensuring that the blade 303 is sufficiently flexible such that it can be easily compressed into the stored configuration and such that it deforms enough to achieve desired flow rates.
[0087] In some embodiments, the thickness of each blade can vary along the height h of the blade. For example, the blades can be thinner at the root of the blade 303, e.g., near the hub 301, and thicker at the free end of the blade 303, e.g., near the wall W of the cannula housing 202. As best seen in FIGS. 5B-5C , for example, the leading edge of the blade can have a first thickness t1a at the fixed end of the blade 303 and a second thickness t1b at the free end of the blade 303. Moreover, the trailing edge of the blade 303 can have a first thickness t2a at the fixed end of the blade 303 and a second thickness t2b at the free end of the blade 303. Because the blades 303 are relatively thin near the hub 301, the blades 303 can be easily folded into the stored configuration due to their increased flexibility near the hub 301. Because the blades 303 are relatively thick at the free end (e.g., near the cannula wall W), the blades 303 may deform a suitable amount when the impeller rotates, reducing the risk that the blades 303 will contact or impact the wall W, which can accordingly reduce the risk of hemolysis, while deforming enough to achieve desirable flow rates. Moreover, in some embodiments, the thickness may vary continuously, such that there are no steps or discontinuities in the thickness of the blade. For example, even though the free end of the blades may be thicker in some embodiments, the thickness can continuously increase along the height of the blade.
[0088] As an example, the first thickness t1a of the leading edge of the blade in FIGS. 5A-5C can be in a range of about 0.016 inches to about 0.023 inches near the hub (e.g., about 0.02 inches at the hub in some arrangements), while the second thickness t1b can be in a range of about 0.022 inches to about 0.028 inches at the free end (e.g., about 0.025 inches at the free end in some arrangements). Further, at the trailing edge of the blade of FIGS. 5A-5C , the first thickness t2a can be in a range of about 0.016 inches to about 0.023 inches near the hub (e.g., about 0.02 inches at the hub in some arrangements), and the second thickness t2b can be in a range of about 0.03 inches to about 0.04 inches at the free end (e.g., about 0.035 inches at the free end in some arrangements). As another example, for the blade of FIGS. 10A-10B , the first thickness t1a of the leading edge can be in a range of about 0.022 inches to about 0.028 inches at the hub (e.g., about 0.025 inches near the hub in some arrangements), and the second thickness t1b can be in a range of about 0.022 inches to about 0.028 inches at the free end (e.g., about 0.025 inches at the free end in some arrangements). At the trailing edge of the blade of FIGS. 10A-10B , the first thickness t2a can be in a range of about 0.016 inches to about 0.023 inches at the hub (e.g., about 0.02 inches in some arrangements), and the second thickness t2b can be in a range of about 0.016 inches to about 0.023 inches at the free end (e.g., about 0.02 inches in some arrangements).
Fillets at Root of Blades
[0089] As explained above, a first fillet 311 can extend along the suction side 305 of each blade 303 at the proximal end of the blade 303 (e.g., at the root of the blade), and a second fillet 313 can extend along the pressure side 307 of each blade at the proximal end of the blade 303. In general the first fillet 311 can have a larger radius than the second fillet 313. The larger fillet 311 can be configured to apply a restoring force when the impeller 300 rotates in the operational configuration. As the impeller 300 rotates, the blades 303 may tend to deform in the distal direction in some situations (e.g., toward the distal portion of the hub 301). By forming the fillet 311 at the suction side 305 of the blade, the curvature of the fillet can advantageously apply a restoring force to reduce the amount of deformation and to support the blade.
[0090] By contrast, the second fillet 313 formed on the pressure side 307 of the blade 303 can have a smaller radius than the first fillet 311. The second fillet 313 can be configured to enhance the folding of the blade against the impeller when the blades 303 are urged into the stored configuration.
[0091] The radius r of each fillet can be any suitable value. For example, the radius r1 of the first fillet 311 can range between about 0.006 inches and about 0.035 inches. The radius r2 of the second fillet 313 can range between about 0.001 inches and about 0.010 inches. Other fillet radiuses may be suitable. For the implementation of FIGS. 5A-5C , for example, the radius r1 of the first fillet 311 can be about 0.015 inches, and the radius r2 of the second fillet 313 can be about 0.005 inches. By contrast, for the impeller shown in FIGS. 10A-10B , the first fillet 311 can have a radius r1 of about 0.025 inches, and the second fillet 313 can have a radius r2 of about 0.005 inches.
Wrapping Angle
[0092] In some implementations, the wrapping angle of each blade can be designed to improve pump performance and to enhance folding of the impeller into the stored configuration. In general, the blades can wrap around the hub at any suitable angle. It has been found that wrapping angles of between about 150 degrees and about 220 degrees can be suitable for folding the blades into the stored configuration. Further, wrapping angles of between about 180 degrees and about 200 degrees can be particularly suitable for folding the blades into the stored configuration.
Ramping Surface
[0093] Furthermore, as explained above, the trailing edge or the proximal end of each blade can include a ramp or chamfer formed at an angle θ with a plane perpendicular to the hub 301, as illustrated above in, e.g., FIG. 5C . FIG. 12 is a schematic, side cross-sectional view of an impeller 1200 having a hub 1201 and one or more blades 1203 disposed within a housing 1202, similar to the housing 202 described above. As shown in FIG. 12 , the impeller 1200 is in the expanded or deployed configuration. For example, the impeller 1200 may be in the deployed configuration before packaging and shipping to a customer. Alternatively, the impeller 1200 may be in the deployed configuration after pumping blood in a patient and before withdrawal of the pump from the vasculature. As explained above, it can be desirable to compress the impeller 1200 into the stored configuration for inserting or withdrawing the operative device of the pump from the patient. To assist in compressing the impeller 1200 into the stored configuration, the blade(s) 1203 can include a ramp 1215 forming a ramp angle θ with a plane perpendicular to the hub 1201.
[0094] An outer sheath or sleeve 1275 can be provided around an elongate body that extends between an operative device of the pump and the motor in the system. The sleeve 1275 can be used to deploy the impeller 1200 from the stored configuration to the deployed configuration and to compress the impeller 1200 from the deployed configuration back into the stored configuration. When compressing and storing the impeller 1200 and the housing 1202, for example, a user, such as a clinician, can advance the sleeve 1275 in the +x-direction, as shown in FIG. 12 . When urged in the +x-direction, the sleeve 1275 can bear against a contact portion 1235 of the housing 1202. The contact portion 1235 of the housing 1202 can in turn bear against the ramp 1215. Advantageously, the ramp angle θ can be angled distally such that when the sheath or sleeve 1275 is urged over the impeller 1200 and housing 1202, the contact portion 1235 can contact the angled or ramped edge of the blades to compress the blades against the hub. The ramp angle θ can be any suitable angle. For example, in some embodiments, the ramp angle θ can be between about 30 degrees and about 50 degrees. In the implementation of FIGS. 5A-5C and 12 , for example, the chamfer or ramp angle θ of the ramp 1215 can be in a range of about 40 degrees to 50 degrees (e.g., about 45 degrees in some arrangements). In the embodiment of FIGS. 10A-10B , the ramp angle θ of the trailing edge can be in a range of about 35 degrees to 45 degrees (e.g., about 40 degrees in some arrangements). Still other ramp angles θ may be suitable to assist in storing the impeller. In some embodiment, the ramp 1215 can comprise a solid, relatively stiff portion against which the housing 202 and sheath may be advanced.
Blade Height-to-Hub Diameter Ratio
[0095] In some embodiments, a ratio σ of blade height (h) to hub diameter (D) can be defined. As explained above, the hub 301 can have a first diameter D1 at a distal end portion of the impeller 300 (e.g., near a leading edge of the blade(s) 303) and a second diameter D2 at a proximal end portion of the impeller 300 (e.g., near a trailing edge of the blade(s) 303). As used herein, the ratio or may be defined relative to a diameter D, which, in some embodiments, may correspond to the first diameter D1 or the second diameter D2, or to an average of D1 and D2. The blade height h may be identified relative to the deployed configuration in some embodiments. As shown in FIGS. 5A-11 , the height h may be defined by a maximum distance between the hub 301 and the free end of the blade(s) 303.
[0096] The ratio σ may be relatively large compared to conventional impellers. For example, as explained herein, it can be advantageous to provide for an impeller 300 having a low profile suitable, for example, for percutaneous insertion into the patient's vascular system. One way to provide a low profile impeller 300 is to reduce the volume of impeller material that is compressed within the outer sheath, e.g., the sheath within which the impeller 300 is stored during percutaneous delivery and insertion. Impellers having relatively large blade height-to-hub diameter ratios σ may allow for such compact insertion, while maintaining high flow rates. For example, larger blade heights h can allow for the use of smaller hub diameters D, and the larger blade heights h are also capable of inducing high flow rates that are advantageous for catheter pump systems. For example, in some embodiments, the blade height-to-hub diameter ratio σ can be at least about 0.95, at least about 1, at least about 1.1, and/or at least about 1.2, in various arrangements. In some embodiments, for example, the ratio σ can be in a range of about 0.7 to about 1.45 in various embodiments. In particular, the ratio σ can be in a range of about 0.7 to about 1.1 in some embodiments (such as the embodiment of FIGS. 10A-10B , for example). In addition, in some arrangements, the ratio σ can be in a range of about 0.75 to about 1. In some embodiments, the ratio σ can be in a range of about 0.9 to about 1.1.
Example Impeller Parameters
[0097] It should be appreciated that the values for the disclosed impeller parameters are illustrative only. Skilled artisans will appreciate that the blade parameters can vary according to the particular design situation. However, in particular embodiments, the blade parameters can include parameter values similar to those disclosed in Tables 1-2 below. Note that length dimensions are in inches and angles are in degrees.
[0098]
| TABLE 1 | ||||||||
|---|---|---|---|---|---|---|---|---|
| FIG. | No. of | D1 | D2 | h | t1a | t1b | t2a | t2b |
| Number | Blades | (in.) | (in.) | (in.) | (in.) | (in.) | (in.) | (in.) |
| 5A-5F | 2 | 0.081 | 0.125 | 0.0995 | 0.02 | 0.025 | 0.02 | 0.035 |
| 6 | 2 | 0.081 | 0.125 | 0.1 | 0.02 | 0.02 | 0.015 | 0.02 |
| 7 | 3 | 0.0844 | 0.125 | 0.1025 | 0.015 | 0.015 | 0.02 | 0.02 |
| 8 | 2 | 0.097 | 0.12 | 0.107 | 0.015 | 0.02 | 0.015 | 0.02 |
| 10A-10B | 3 | 0.0836 | 0.125 | 0.107 | 0.025 | 0.025 | 0.02 | 0.02 |
| 11 | 2 | 0.0798 | 0.125 | 0.109 | 0.03 | 0.025 | 0.015 | 0.02 |
[0099]
| TABLE 2 | ||||||
|---|---|---|---|---|---|---|
| Wrap | ||||||
| FIG. | β | Angle | r1 | r2 | R | |
| Number | (deg) | (deg) | θ (deg) | (in.) | (in.) | (in.) |
| 5A-5F | 40 | 210 | 45 | 0.015 | 0.005 | 0.12 |
| 6 | 40 | 210 | 45 | 0.015 | 0.005 | 0.07 |
| 7 | 40 | 270 | 46 | 0.015 | 0.005 | 0.133 |
| 8 | 40 | 200 | 40 | 0.015 | 0.005 | 0.12 |
| 10A-10B | 40 | 220 | 40 | 0.025 | 0.005 | 0.133 |
| 11 | 30 | 210 | 35 | 0.015 | 0.005 | 0.09 |
[0100] One will appreciate from the description herein that the configuration of the blades may be modified depending on the application. For example, the angle of attack of the blades may be modified to provide for mixed flow, axial flow, or a combination thereof. The exemplary blades of the illustrated figures are dimensioned and configured to improve axial flow and reduce hemolysis risk. The exemplary blades are shaped and dimensioned to achieve the desired pressure head and flow rate. In addition, the single blade row design is thought to reduce the turbulent flow between blade rows with other designs and thus may reduce hemolysis.
Flow Modifying Structures
[0101] The impeller designs discussed herein are fully capable of providing flows to meet patient needs, as discussed below. However, pump performance can be even further improved by incorporating flow modifying structures downstream of the impeller, e.g., a stator or other structure providing flow directing or modifying structure (e.g. blades) in the flow stream. The flow modifying structures advantageously aligns a rotational, complex flow field generated by the high speed rotation of any of the impellers described herein into a more uniform and laminar flow, in some cases a substantially laminar. This alignment of the flow converts rotational kinetic energy near the blades into pressure. Absent the flow modifying structures, the energy in the complex field would be dissipated and lost. This alignment of the flow reduces losses due to the disorganized nature of the flow exiting an impeller.
[0102] FIGS. 15-19 show details of a catheter assembly 400 and an exemplary flow modifying structure 402 disposed in a distal portion of the assembly 400 downstream from the impeller. The flow modifying structure can be a stator or stator assembly. The flow modifying structure 402 can include a blade body 404 having one or a plurality of, e.g., three, blades 408 extending outwardly from a central body 412. In the exemplary embodiment, flow modifying structure 402 is a stator having a plurality of blades 408 configured to align or straighten flow from the impeller in an axial direction. FIG. 19 shows that central body 412 is hollow, enabling it to be mounted on a structure of the catheter assembly 400. The blade body 404 is at a downstream location of the impeller 300. In a percutaneous left ventricle application, the blade body 404 is disposed proximal of the impeller 300. In a percutaneous right ventricle application, the blade body 404 is located distal of the impeller 300. In a transapical approach to aid the left ventricle, which might be provided through ports in the chest wall or via thoracotomy or mini-thoracotomy, the stator blade body 404 is disposed distal of the impeller 300. It should be appreciated that the flow directing structure 402 described herein may be implemented with any of the impellers 300-300J disclosed herein to improve pump performance.
[0103] The flow modifying structure 402 can be formed as a unitary body with collapsible blades 408. The exemplary blades 408 are collapsible and resiliently expandable, e.g., by releasing stored strain energy. In some embodiments, at least the blades 408 are actuatable to an expanded state and do not require storing and releasing stored strain energy. For example, the blades 408 can be inflatable or actuated by some mechanical means such as a pull wire to be enlarged from a low profile delivery state to an operational state.
[0104] The blades 408 are configured to act on the fluid flow generated by the impeller 300 to provide a more clinically useful flow field (e.g., laminar) downstream of the flow modifying structure 402. The blades 408 can improve efficiency by changing the flow field from the impeller into a more clinically useful flow field as it is output from the catheter pump 10. The blades 408 transform complex, mostly radial flow vectors generated by the impeller 300 into more uniform axial flow vectors. In some cases, the blades 408 are configured to reduce other inefficiencies of the flow generated by the impeller 300, e.g., minimize turbulent flow, flow eddies, etc. Removing radial and/or circumferential flow vectors of the flow can be achieved with blades that are oriented in an opposite direction to the orientation of the blades of the impeller 300, for example, clockwise versus counterclockwise oriented blade surface. For example, the wrapping direction of the blades of FIG. 10A is the opposite of that of the blades in FIG. 18 .
[0105] While the blades 408 act on the flow generated by the impeller 300, the fluids also act on the flow modifying structure 402. For example, the blade body 404 experiences a torque generated by the interaction of the blades 408 with the blood as it flows past the assembly 402. A mechanical interface is provided between the central body 412 and a distal portion of the catheter assembly 400. For example, the central body 412 of the flow modifying structure 402 can be mounted, on a housing that also supports rotation of the impeller 300. Preferably the interface is self-tightening, as discussed in U.S. patent application Ser. No. 13/801,833, filed Mar. 13, 2013, entitled “SHEATH SYSTEM FOR CATHETER PUMP,” which is incorporated by reference herein in its entirety.
[0106] An important feature of the catheter assembly 400 is defining a small gap G between the flow modifying structure 402 and the impeller 300. The gap G is provided to accommodate relative motion between the impeller 300 and the flow modifying structure 402. The flow modifying structure 402 can be held in a constant rotational position, while the impeller 300 rotates at a high rate. The gap G helps to reduce friction between and wear of the impeller 300 and the central body 412 of the flow modifying structure 402. The gap G should not be too large, however, to provide appropriate flow between the blades of the impeller 300 and the stator blades 408. A large gap could provide a high pressure drop (i.e. hydraulic efficiency loss), which his disadvantageous. As discussed more below, the blades 408 modify the flow characteristics of blood between the impeller 300 and an outlet of the cannula 202.
[0107] FIGS. 15-19 illustrate more features of the flow modifying structure 402. The blades 408 preferably extend along a distal length of the blade body 404. The blades 408 can extend from a leading edge 420 to a trailing edge 424 between a blade root 428 and a distal edge 432. The leading edge 420 can be any suitable shape to minimize inefficient transfer flow from the impeller 300. For example, the blade 408 can have a convex expanse 436 disposed between the leading and trailing edges 420, 424.
[0108] In FIG. 17 the convex expanse 436 is formed to follow a curve profile of the distal edge 432 of the blade 408. The convex expanse 436 has a complex curved shape including a distal portion that has relatively high curvature and a proximal portion that has less curvature. The relative curvatures can be seen in comparing the leading edge portion in of blade 408A and the curvature of the trailing edge portion of the blade 408B in FIG. 17 . In this embodiment, the blades 408A, 408B are identical but are mounted at spaced apart locations, e.g., 120 degrees from each other. Though the structure is not easily rendered in a two dimensional format, the portion A at the leading edge 420 has a higher curvature than the portion B disposed between the leading edge 420 and the trailing edges 424.
[0109] A gradual reduction in the degree of curvature is preferred to act on the blood directed proximally from the impeller 300. The flow generated by the impeller 300 can be characterized as a complex flow field. A gradual change in the angle of the blades 408 will efficiently transform the complex flow field into a more unified, ordered field, e.g., generally axially directed and more laminar. The blades 408 reduce the rotational inertia of the flow that tends to carry the flow circumferentially and radially outwardly to direct the flow proximally, while minimizing turbulence and other inefficient flow regimes. A tangent to the curvature of the distal edge 432 is indicative of the direction in which the blade 408 will tend to direct the flow interacting with the blade 408. In the region A, a tangent to the curve of the distal edge 432 (or the expanse 436 or 440) can be disposed at an angle α to a line parallel to the longitudinal axis of the central body 412. The angle α is shown on FIG. 18 . The angle α is selected to allow the blood flowing off of the impeller to enter the space defined between the expanse 436 and the expanse 440 on adjacent blades (see FIG. 17 ). The angle α can be less than about 60 degrees in one embodiment, and less than about 50 degrees in another embodiment, in some embodiments less than about 45 degrees. The angle α can be between about 30 degrees and about 70 degrees, and in some cases between about 40 and about 60 degrees.
[0110] In the region B, a tangent to the curve of the distal edge 432 (or the expanse 436 or 440) is at a relatively low angle to a preferred flow direction. In one embodiment, it is preferred that the flow within the channel defined between the expanse 436 and the expanse 440 of adjacent blades approach a direction that is more axial than the flow in the area of the impeller 300 and more axial than downstream of the impeller 300 where the stator assembly 402 not present. In some cases, the flow in the channel defined between the expanse 436 and the expanse 440 of adjacent blades approaches a direction generally parallel to the longitudinal axis of the catheter assembly 400. The angle of the structures of the blades in the region B, e.g., the tangent to the curvature at the distal edge 432, is between about 20 and about 50 degree, and in some cases between about 30 and about 40 degrees and in some cases between 35 and about 45 degrees.
[0111] In some embodiments, the angle of trailing edge features relative to the desired direction of flow is a feature that can be advantageously controlled. For example, the angle β can be provided between the blade root 428 in the region C and an axis parallel to the longitudinal axis of the central body 412 of the stator assembly 402. The angle β is between about zero and about 30 degrees, and in some cases is between about 5 and 20 degrees, and in other cases is no more than about 20 degrees, and can be less than about 10 degrees.
[0112] FIG. 18 shows that the angles α and β define a flow channel between the expanse 436 of the blade 408A and the expanse 440 of the blade 408B. The expanse 436 can include one side of the blade 408A and the expanse can include one side of the blade 408B. A leading edge portion of the channel defined in this manner has relatively high curvature along the sidewalls. A trailing edge portion of the channel defined in this manner has relatively low curvature along the sidewalls. The change in curvature helps shape the average flow direction of the flow of blood coming from the impeller 300 and exiting the channels in the stator assembly 402.
[0113] As discussed herein, the catheter pumps herein are configured for low profile delivery but the impeller 300 is expandable to provide for superior flow performance. The blades 408 of the flow modifying structure 402 closely match the profile of the blades of the impeller 312. For example, in the deployed state, the blades of the impeller 312 extend a distance from a blade root by a distance that is about the same distance as is measured from the blade root 428 to the blade distal end 432. Because the blades 408 are to be delivered through the same profile as the impeller, the blades 408 are also to be collapsible in some embodiments.
[0114] Various features may be provided to facilitate deployment and collapse of the flow modifying structure 402. Fillets 411, 413 similar to those hereinbefore described in connection with the impeller 300 can be provided to facilitate stability of the stator blades 408 in operation of the pump and the collapse of the stator blades. The fillets 411, 413 preferably have a first portion disposed on the central body 412 and a second portion disposed at the junction of the blade root 428 with the convex expanse 436 and the concave expanse 440. In one stator collapse strategy, the blades are configured to fold distally and into the direction of curvature of the distal edge 432. In other words, the expanse 436 is moved toward the central body 412 upon advancement of a distal end of the sheath assembly 88 discussed above. More particularly, relative axial motion of the distal end of the sheath assembly 88 over the trailing edge 424 of the blades 408 causes bending around the fillet 411 disposed between the expanse 436 and the central body 412. The bending is initially at the trailing edge 424 and progresses toward the leading edge 420 until the expanse 436 of each blade is folded down onto a corresponding portion on of the central body 412 between the expanse 436 and an expanse 440 of an adjacent blade.
[0115] Another feature that facilitates collapse is the configuration of the trailing edge 424. The trailing edge 424 is disposed at an angle θ relative to an axis parallel to the longitudinal axis of the central body 412 of the stator assembly 402. The angle θ may be any of those discussed above in connection with the ramped surface of the impellers 300. The angle θ can be in a range of about zero to about 70 degrees. In some embodiments, the angle θ can be in a range of about 20 to about 60 degrees, in other embodiments, the angle θ can be between about 30 and 55 degrees. In other embodiments, the angle θ can be less than about 60 degrees.
[0116] A trailing edge cylindrical portion 454 is disposed between the trailing edges of the fillets 411, 413 and the proximal end of the central body of the stator assembly 402. The cylindrical portion 454 spaces the trailing edges 424 and the fillets 411, 413 from the boundary between the central body 412 and more proximal portions of the catheter assembly 400. This allows blood to transition from three separate flows in the region of the blades to a single unified flow field between the proximal most portion of the trailing edge 424 and the transition from the cylindrical body 412 to another more proximal structure. By separating these transitions axially the flow is maintained more organized, e.g., is less likely to become more turbulent due to complex circumferential, radial, and axial boundaries.
Improving Patient Outcomes
[0117] As explained herein, it can be desirable to pump blood at relatively high flow rates in order to provide adequate cardiac assistance to the patient and to improve patient outcomes. It should be appreciated that, typically, higher impeller rotational speeds may increase flow rates because the impeller is driven at a higher speed. However, one potential disadvantage of high impeller speeds is that blood passing across or over the rotating components (e.g., the impeller and/or impeller shaft or hub) may be damaged by the shearing forces imparted by the relatively rotating components. Accordingly, it is generally desirable to increase flow rates for given rotational impeller speeds.
[0118] The various features disclosed herein can enable a skilled artisan to provide an impeller capable of increasing or maintaining flow rates at lower rotational impeller speeds. These improvements are not realized by mere increases in rotational speed or optimization of the impeller design. Rather, the improvements lead to a significant shift in the performance factor of the impeller, which reflect structural advantages of the disclosed impellers.
[0119] FIG. 13 is a chart plotting flow rate versus motor speed for the impellers illustrated in FIGS. 10A-10B and 9E . Note that, in the illustrated chart of FIG. 13 , however, that the impeller speed is the same as the motor speed, e.g., no clutch is used between the motor and impeller shaft. Thus, the plotted values in FIG. 13 represent flow rates at various impeller rotational speeds. The flow rates were measured by running the impellers on a closed mock loop on the bench with a blood analog. The back pressure (e.g., head pressure or change in pressure across the pump) was at about 62 mmHg for the impellers 300D, 300J of FIGS. 10A-10B and 9E , respectively. The results on the bench top mirror those achieved in animal investigations.
[0120] As shown in FIG. 13 , the impeller 300D provides for higher flow rates at lower speeds than the impeller 300J of, e.g., FIG. 9E . For example, the impeller 300J of FIG. 9E may be capable of pumping blood at flow rates in a range of about 4.5 liters per minute (LPM) to about 5.5 LPM when the impeller is operating at speeds in a range of about 25,000 revolutions per minute (RPMs) to about 28,000 RPMs. For example, the impeller of FIG. 9E may be capable of pumping blood at a flow rate of about 5.5 LPM when the impeller is operating at speeds in a range of about 26,000 RPMs to about 28,000 RPMs.
[0121] In FIG. 13 , the flow rate of the impeller 300J can be plotted along a line X, in which flow rate increases with impeller rotational speed, which is the same as motor speed in FIG. 13 . With prior designs, increased flow rate can only be achieved by increasing the rotational speed to move along the line X. Prior, it was expected that optimization of the impeller design can only realize minor improvements to the flow versus RPM curve. At best, the impeller could be configured to achieve minor improvements at the extremes or with a slight change in the curve X, such that the line or curve X might have a slightly higher slope.
[0122] For example, with the impeller 300J of FIG. 9E , the impeller speed at data point X1 is about 21,000 RPM, which yields a flow rate of about 1.9 LPM. With the impeller 300J of FIG. 9E , flow rate can indeed be increased to above about 5 LPM, e.g., about 5.4 LPM, at data point X2, but the impeller rotational speed required to achieve such improvements in flow rate also increases to about 27,000 RPM. Thus, even though the impeller 300J of FIG. 9E can achieve relatively high flow rates, the high flow rates come at the expense of a higher impeller speed, which, as explained above, can cause hemolysis and undesirable patient outcomes.
[0123] By contrast, the impeller 300D of FIGS. 10A-10B achieves significant and unexpected performance improvements. The exemplary impeller has been found to achieve dramatically higher flow rates at all rotational speeds. For example, the impeller 300D of FIGS. 10A-10B can achieve flow rates above 4.25 LPM, indeed even above about 5 LPM, while maintaining a low impeller speed of less than about 21,000 RPM (which, by contrast, induced a flow rate of only about 1.9 LPM in the impeller 300J of FIG. 9E ). Thus, the design of the impeller 300D of FIGS. 10A-10B can advantageously achieve structural advantages relative to the impeller 300J. Indeed, the curve labeled Yin FIG. 13 illustrates the dramatic shift of the flow rate curve to the left in FIG. 13 , which indicates significantly increased flow rates at lower impeller speeds relative to prior impeller designs. The exemplary impeller has also been found to have a dramatically improved head pressure versus flow rate (HQ) performance versus conventional designs.
[0124] The exemplary impeller 300D of FIGS. 10A-10B has been found to be capable of pumping blood at flow rates in a range of about 4.5 LPM to about 5.5 LPM when the impeller is operating at speeds in a range of about 19,000 RPM to about 21,000 RPM, e.g., when the impeller is operating at speeds less than about 21,000 RPMs. For instance, the impeller 300D of FIGS. 10A-10B may be capable of pumping blood at a flow rate of about 5.5 LPM when the impeller is operating at speeds in a range of about 20,000 RPMs to about 21,000 RPMs. Further, the impeller 300D of FIGS. 10A-10B may be capable of pumping blood at a flow rate of about 5 LPM when the impeller is rotating at speeds in a range of about 19,000 RPMs to about 21,000 RPMs. In some arrangements, when the impeller is operating at a speed of about 19,500 RPMs, the flow rate may be in a range of about 4.5 LPM to about 5.1 LPM.
[0125] Further, the impeller 300D of FIGS. 10A-10B is capable of pumping blood at a flow rate of at least about 3.5 LPM, and/or at least about 4.25 LPM, when the impeller is operating at speeds less than about 21,000 RPMs. For example, the impeller 300D is capable of pumping blood at a flow rate of at least 4.25 LPM when the impeller is operating at speeds in a range of about 18,500 RPM to about 22,000 RPM, for example in a range of about 18,500 RPM to about 21,000 RPM. For example, the impeller 300D is capable of pumping blood at a flow rate in a range of about 4.25 LPM to about 5.5 LPM when the impeller is operating at speeds in a range of about 18,500 RPM to about 21,000 RPM. The flow rates achieved at these impeller speeds may be achieved at a back pressure or head pressure of at least 60 mmHg, e.g., at about 62 mmHg in some embodiments. Further the impeller 300D capable of achieving the performance of FIG. 13 may also be sized and shaped to be inserted into a vascular system of a patient through a percutaneous access site having a catheter size less than about 21 FR.
[0126] The impeller 300D of FIGS. 10A-10B may therefore provide a dramatic and unexpected jump in flow rates relative to the impeller 300J of FIG. 9E . The shift in performance allows the impeller 300D to achieve a maximum flow rate far exceeding conventional and/or previous designs and at a rotational speed a mere fraction of that for which conventional pumps are designs. Thus, FIG. 13 illustrates that the impeller 300D of FIGS. 10A-10B yields improved patient outcomes and reduced hemolysis relative to the impeller 300J of FIG. 9E .
[0127] FIG. 14 is a chart plotting flow rate versus motor speed (e.g., impeller speed) for an impeller similar to or the same as the impeller 300D of FIGS. 10A-10B , as compared to various conventional microaxial, rotary pumps. In particular, Curve A in FIG. 14 plots flow rate versus motor speed (again, the same as impeller speed in FIG. 14 ) for the impeller associated with Curve A, according to test data taken using a blood analog at about 62 mmHG back pressure.
[0128] Curve B plots approximate flow rate versus motor speed for the heart pump disclosed in the article of J. Stolinski, C. Rosenbaum, Willem Flameng, and Bart Meyns, “The heart-pump interaction: effects of a microaxial blood pump,” International Journal of Artificial Organs, vol: 25 issue: 11 pages: 1082-8, 2002, which is incorporated by reference herein in its entirety and for all purposes. The test data from Curve B was obtained under test conditions having a back pressure of about 60 mmHg.
[0129] Curve C plots approximate flow rate versus motor speed for the heart pump disclosed in the article of David M. Weber, Daniel H. Raess, Jose P. S. Henriques, and Thorsten Siess, “Principles of Impella Cardiac Support,” Supplement to Cardiac Interventions Today, August/September 2009, which is incorporated by reference herein in its entirety and for all purposes. The test data from Curve C was obtained under test conditions having a back pressure of about 60 mmHg.
[0130] Data point D plots approximate flow rate versus motor speed for the heart pump disclosed in Federal and Drug Administration 510(k) Summary for Predicate Device IMPELLA 2.5 (K112892), prepared on Sep. 5, 2012, which is incorporated by reference herein in its entirety and for all purposes. In particular, for data point D, the disclosed pump was capable of mean flow rates of up to 3.3 LPM at pump speeds of 46,000 RPM at a 60 mmHg differential pressure.
[0131] As shown in FIG. 14 , the disclosed impeller associated with Curve A can achieve higher flow rate at all impeller speeds relative to the pumps of Curves B, C, and D. The data reflected in FIG. 14 was not all collected by precisely the same methodology in a head-to-head fashion, as noted above. However, the data are shown on a single chart for the convenience of the reader and are still compelling. For example, as discussed above, the back-pressure conditions under which the Curve A data was collected (for impellers disclosed herein) was higher than that collected for the other devices. Were this test condition the same, the results would be all the more impressive. Indeed, data points A1 and A2 of Curve A, for example, provide higher flow rates at significantly lower impeller rotation rates than any of the data points along Curves B-C or at point D (e.g., data points B1, B2, B3, C1, C2). In addition, as shown in FIG. 14 , the impeller of Curve A can achieve flow rates of about 7 LPM at impeller speeds of only about 25,000 RPM, as shown by Curve A. By contrast, curves B-C and data point D do not even indicate that the conventional axial pumps can achieve 7 LPM flow rates at any impeller speed. Thus, the impeller associated with Curve A of FIG. 14 can achieve higher flow rates at lower rotational speeds than conventional catheter pumps, such as microaxial, rotary pumps, (e.g., Curves B-C and data point D of FIG. 14 ). In addition, the disclosed impellers can also be configured to achieve higher maximum flow rates than conventional pumps.
[0132] In addition, the data of Curves B-C and data point D of FIG. 14 represent another constraint on the design of conventional rotary pumps. For example, the pump plotted on Curve B has a diameter corresponding to a catheter size of about 21 FR. Flow rates may be increased for the pump of Curve B by increasing the diameter of the pump. However, further increases in pump diameter for the device of Curve B may disadvantageously increase the pump diameter requiring more invasive techniques to position the pump. Thus, increasing flow rate by increasing pump diameter may not be a feasible or desirable alternative for catheter pumps, and/or it may not be desirable for acute heart failure where fast implantation is critically important.
[0133] By contrast, as shown in Curve A of FIG. 14 , the impeller (e.g., which can be the same as or similar to the impeller 300D disclosed herein) advantageously has an insertion diameter corresponding to a catheter size of less than about 13 FR, e.g., about 12.5 FR in some embodiments, which can enable minimally-invasive insertion techniques, even at higher flow rates and lower impeller rotation rates. Thus, the disclosed impeller of Curve A can provide higher flow rates at lower impeller speeds than conventional microaxial, rotary pumps, and can maintain lower insertion diameters for minimally invasive techniques.
[0134] Indeed, the impeller of Curve A may be configured to be inserted into vascular system of a patient through a percutaneous access site having a size less than 21 FR. The impeller of Curve A (e.g., which may be similar to or the same as impeller 300D) may include one or more blades in a single row. In some embodiments, the impeller can be configured to pump blood through at least a portion of the vascular system at a flow rate of at least about 2.0 liters per minute when the impeller is rotated at a speed less than about 21,000 revolutions per minute. In some embodiments, the blades are expandable.
[0135] FIG. 14A shows a performance curve for several catheter pumps to illustrate the capability of a catheter pump that includes the catheter assembly 400. Catheter pump performance can be characterized by the relationship between the pump's pressure differential H and flow rate Q at a given rotor speed S. This relationship can be represented by a map or graph, as shown in FIG. 14A . In FIG. 14A , the pressure differential H is represented by the Y axis and the flow rate Q by the X axis. For a given pump speed, the relationship between the pressure differential H and the flow rate Q is represented by an H-Q curve on the graph. As a result, a map of the continuous flow pump includes a family of H-Q curves, each curve representing a relationship between the pressure differential H and the flow rate Q for every different pump speed S.
[0136] The family of H-Q curves in FIG. 14A represents the H-Q characteristics of the pump 10 with the catheter assembly 400 and several other pumps. The native H-Q characteristics, including the shape, steepness (slope) and location of individual H-Q curves, is generally unique to the particular hydraulic design of pump and varies from one pump to another. As used herein, “H-Q” is an abbreviation for “pressure-flow.” The phrases “H-Q curve” and “pressure-flow curve” have the same meaning and are used interchangeably. The phrases “H-Q characteristics” and “pressure-flow characteristics” have the same meaning and are used interchangeably.
[0137] FIG. 14A is a map of an axial flow pump generated by test data as would be understood by one of skill in the art. The term “map” refers to mapping of relationships between pressure differential H, flow rate Q and rotor speed S.
[0138] In FIG. 14A , the actual or expected performance of each of four distinct pumps is illustrated. A first pump is illustrated by a consistent dashed line, and labeled “Conventional Pump C”. This line represents the pump performance of an Impella® 2.5 pump based on published data in “Principles of Impella Cardiac Support”, referenced above. A second pump, labeled “Convention Pump D” is illustrated by a triangle at a single point. This data is included in a 510(k) submission to the United Stated FDA for Impella® 2.5 Plus, discussed above. A third pump (“A-1”) is illustrated by a series of solid lines, and corresponds to a pump having an expandable impeller similar to those discussed herein. A pump including flow modifying structures similar to the flow direction structures 402 was fabricated and tested. The pump test showed about a 15 percent improvement over the performance of a similar pump without the flow modifying structure. It is anticipated that further embodiments will yield a 10-15% increase in head pressure compared to a comparable design without the flow modifying structures. The expected performance of the fourth pump including the catheter assembly 400 (“A-2”) is illustrated in line with repeating dash and two dots.
[0139] As can be seen, for the first three curves where data was collected or retrieved from the literature by the assignee of this application, the pump A-1 has far superior performance overall. The family of curves for the pump A-1 demonstrates higher maximum flow rates than either Convention Pump C or D. Comparable or larger flow rates are achieved with impeller speeds that are significantly less than that of the other pumps for which data was collected or available. For example, for Conventional Pump D the motor speed required to obtain the flow rate as charted was 45,000 RPM whereas the pump A-1 achieved comparable flows at only 19,000 RPM. As discussed herein, these lower impeller speeds for pump A-1 are expected to provide much superior patient outcomes at least because hemolysis and other potentially deleterious blood interactions at the impeller will be dramatically reduced.
[0140] The pump A-2 is expected to provide even higher flow performance than that of pump A-1. The chart illustrates the expected H-Q performance at 22,000 RPM for a pump including the catheter assembly 400. The improved performance relates to a transformation of the flow field coming off of the impeller 300 into a more laminar state from a more complex flow field. The transformation converts kinetic energy associated with a rotational component of the flow into additional pressure, enhancing the performance. This line suggests a number of possible improvements that could be implemented in the operation or configuration of the pump A-2. For example, if the impeller diameter is the same in the pump A-2 as in the pump A-1, the pump A-2 could operate at a lower RPM while providing the same output (flow rate) as that of the pump A-1. Or, if the pump A-2 is operated at the same speed as the pump A-1, the output could be higher with the pump A-2 for comparable amount of hemolysis.
[0141] A third advantage in view of the performance of the pump A-2 is that a smaller device could be made that would achieve the same output as the pump A-1 at the same impeller speed. For example, the device could be reduced in size to enable it to be placed in smaller blood vessels or through smaller sheaths such as the femoral artery or smaller vessels in the arterial system. A significant advantage of reducing the size of the pump 10 is that there will be less blockage of flow in the femoral (or similar sized) artery to downstream tissue fed by the vasculature. Blockage can lead to ischemia of the tissue. Avoiding ischemia makes the pump 10 more biocompatible generally and may enable the pump to be used for longer durations or with more patients.
[0142] Although the inventions herein have been described with reference to particular embodiments, it is to be understood that these embodiments are merely illustrative of the principles and applications of the present inventions. It is therefore to be understood that numerous modifications can be made to the illustrative embodiments and that other arrangements can be devised without departing from the spirit and scope of the present inventions as defined by the appended claims. Thus, it is intended that the present application cover the modifications and variations of these embodiments and their equivalents.
Claims
What is claimed is:
1. A catheter pump comprising:
a sheath;
a cannula disposed at a distal portion of the catheter pump and having a stored configuration when disposed within the sheath and an expanded configuration when advanced distally from the sheath; and
an impeller disposed within the cannula and a stator disposed downstream of the impeller within the cannula, the impeller and the cannula sized and shaped, when in the stored configuration, to be inserted into a vascular system of a patient through a percutaneous access site having a size less than about 21 FR,
wherein the impeller, disposed in the cannula in the expanded configuration, is configured to pump blood in the vascular system at physiological rates at speeds less than 25,000 RPM.
2. The catheter pump of claim 1, wherein the catheter pump is configured to pump blood at 5 liters per minute and 62 mmHG at while being operated at speeds less than about 20,000 RPM.
3. The catheter pump of claim 1, wherein the catheter pump is configured to pump blood at 4 liters per minute and 62 mmHG at while being operated at speeds less than about 19,000 RPM.
4. The catheter pump of claim 1, wherein the catheter pump is configured to pump blood at 6 liters per minute and 62 mmHG at while being operated at about 20,000 RPM.
5. The catheter pump of claim 1, wherein the catheter pump is configured to pump blood at 5 liters per minute and 62 mmHG at while being operated at speeds about 19,000 RPM.
Patent Citations (491)
| Patent | Date | Inventor | Cited By |
|---|---|---|---|
| US2789511(A) | 1957-04-01 | Doble | Applicant |
| US3510229(A) | 1970-05-01 | Smith | Applicant |
| US3995617(A) | 1976-12-01 | Watkins et al. | Applicant |
| US4115040(A) | 1978-09-01 | Knorr | Applicant |
| US4129129(A) | 1978-12-01 | Amrine | Applicant |
| US4135253(A) | 1979-01-01 | Reich et al. | Applicant |
| US4143425(A) | 1979-03-01 | Runge | Applicant |
| US4304524(A) | 1981-12-01 | Coxon | Applicant |
| US4382199(A) | 1983-05-01 | Isaacson | Applicant |
| US4458366(A) | 1984-07-01 | MacGregor et al. | Applicant |
| US4537561(A) | 1985-08-01 | Xanthopoulos | Applicant |
| US4589822(A) | 1986-05-01 | Clausen et al. | Applicant |
| US4625712(A) | 1986-12-01 | Wampler | Applicant |
| US4673334(A) | 1987-06-01 | Allington et al. | Applicant |
| US4686982(A) | 1987-08-01 | Nash | Applicant |
| US4696667(A) | 1987-09-01 | Masch | Applicant |
| US4704121(A) | 1987-11-01 | Moise | Applicant |
| US4753221(A) | 1988-06-01 | Kensey et al. | Applicant |
| US4817586(A) | 1989-04-01 | Wampler | Applicant |
| US4846152(A) | 1989-07-01 | Wampler et al. | Applicant |
| US4895557(A) | 1990-01-01 | Moise et al. | Applicant |
| US4900227(A) | 1990-02-01 | Trouplin | Applicant |
| US4902272(A) | 1990-02-01 | Milder et al. | Applicant |
| US4906229(A) | 1990-03-01 | Wampler | Applicant |
| US4908012(A) | 1990-03-01 | Moise et al. | Applicant |
| US4919647(A) | 1990-04-01 | Nash | Examiner |
| US4944722(A) | 1990-07-01 | Carriker et al. | Applicant |
| US4957504(A) | 1990-09-01 | Chardack | Applicant |
| US4964864(A) | 1990-10-01 | Summers et al. | Applicant |
| US4969865(A) | 1990-11-01 | Hwang et al. | Applicant |
| US4985014(A) | 1991-01-01 | Orejola | Applicant |
| US5021048(A) | 1991-06-01 | Buckholtz | Applicant |
| US5044902(A) | 1991-09-01 | Malbec | Applicant |
| US5045072(A) | 1991-09-01 | Castillo et al. | Applicant |
| US5049134(A) | 1991-09-01 | Golding | Applicant |
| US5059174(A) | 1991-10-01 | Vaillancourt | Applicant |
| US5061256(A) | 1991-10-01 | Wampler | Applicant |
| US5089016(A) | 1992-02-01 | Millner et al. | Applicant |
| US5098256(A) | 1992-03-01 | Smith | Applicant |
| US5112292(A) | 1992-05-01 | Hwang et al. | Applicant |
| US5142155(A) | 1992-08-01 | Mauze et al. | Applicant |
| US5163910(A) | 1992-11-01 | Schwartz et al. | Applicant |
| US5169378(A) | 1992-12-01 | Figuera | Applicant |
| US5171212(A) | 1992-12-01 | Buck et al. | Applicant |
| US5190528(A) | 1993-03-01 | Fonger et al. | Applicant |
| US5195960(A) | 1993-03-01 | Hossain et al. | Applicant |
| US5211546(A) | 1993-05-01 | Isaacson et al. | Applicant |
| US5221270(A) | 1993-06-01 | Parker | Applicant |
| US5234407(A) | 1993-08-01 | Teirstein et al. | Applicant |
| US5234416(A) | 1993-08-01 | MacAulay et al. | Applicant |
| US5290227(A) | 1994-03-01 | Pasque | Applicant |
| US5300112(A) | 1994-04-01 | Barr | Applicant |
| US5344443(A) | 1994-09-01 | Palma et al. | Applicant |
| US5376114(A) | 1994-12-01 | Jarvik | Applicant |
| US5393207(A) | 1995-02-01 | Maher et al. | Applicant |
| US5405341(A) | 1995-04-01 | Martin | Applicant |
| US5437541(A) | 1995-08-01 | Vainrub | Applicant |
| US5458459(A) | 1995-10-01 | Hubbard et al. | Applicant |
| US5490763(A) | 1996-02-01 | Abrams et al. | Applicant |
| US5527159(A) | 1996-06-01 | Bozeman, Jr. et al. | Applicant |
| US5534287(A) | 1996-07-01 | Lukic | Applicant |
| US5586868(A) | 1996-12-01 | Lawless et al. | Applicant |
| US5613935(A) | 1997-03-01 | Jarvik | Applicant |
| US5702418(A) | 1997-12-01 | Ravenscroft | Applicant |
| US5704926(A) | 1998-01-01 | Sutton | Applicant |
| US5725513(A) | 1998-03-01 | Ju et al. | Applicant |
| US5735897(A) | 1998-04-01 | Buirge | Applicant |
| US5741234(A) | 1998-04-01 | Aboul-Hosn | Applicant |
| US5741429(A) | 1998-04-01 | Donadio, III et al. | Applicant |
| US5746709(A) | 1998-05-01 | Rom et al. | Applicant |
| US5749855(A) | 1998-05-01 | Reitan | Applicant |
| US5776161(A) | 1998-07-01 | Globerman | Applicant |
| US5776190(A) | 1998-07-01 | Jarvik | Applicant |
| US5779721(A) | 1998-07-01 | Nash | Applicant |
| US5824070(A) | 1998-10-01 | Jarvik | Applicant |
| US5851174(A) | 1998-12-01 | Jarvik et al. | Applicant |
| US5859482(A) | 1999-01-01 | Crowell et al. | Applicant |
| US5868702(A) | 1999-02-01 | Stevens et al. | Applicant |
| US5888241(A) | 1999-03-01 | Jarvik | Applicant |
| US5888242(A) | 1999-03-01 | Antaki et al. | Applicant |
| US5895557(A) | 1999-04-01 | Kronzer | Applicant |
| US5911685(A) | 1999-06-01 | Siess et al. | Applicant |
| US5927956(A) | 1999-07-01 | Lim et al. | Applicant |
| US5941813(A) | 1999-08-01 | Sievers et al. | Applicant |
| US5951263(A) | 1999-09-01 | Taylor et al. | Applicant |
| US5957941(A) | 1999-09-01 | Ream | Applicant |
| US5993420(A) | 1999-11-01 | Hyman et al. | Applicant |
| US6007478(A) | 1999-12-01 | Siess et al. | Applicant |
| US6007479(A) | 1999-12-01 | Rottenberg et al. | Applicant |
| US6015272(A) | 2000-01-01 | Antaki et al. | Applicant |
| US6015434(A) | 2000-01-01 | Yamane | Applicant |
| US6018208(A) | 2000-01-01 | Maher et al. | Applicant |
| US6027863(A) | 2000-02-01 | Donadio, III | Applicant |
| US6053705(A) | 2000-04-01 | Schob et al. | Applicant |
| US6056719(A) | 2000-05-01 | Mickley | Applicant |
| US6058593(A) | 2000-05-01 | Siess | Applicant |
| US6059760(A) | 2000-05-01 | Sandmore et al. | Applicant |
| US6068610(A) | 2000-05-01 | Ellis et al. | Applicant |
| US6071093(A) | 2000-06-01 | Hart | Applicant |
| US6083260(A) | 2000-07-01 | Aboul-Hosn | Applicant |
| US6086527(A) | 2000-07-01 | Talpade | Applicant |
| US6086570(A) | 2000-07-01 | Aboul-Hosn et al. | Applicant |
| US6106494(A) | 2000-08-01 | Saravia et al. | Applicant |
| US6109895(A) | 2000-08-01 | Ray et al. | Applicant |
| US6113536(A) | 2000-09-01 | Aboul-Hosn et al. | Applicant |
| US6123659(A) | 2000-09-01 | Le Blanc et al. | Applicant |
| US6123725(A) | 2000-09-01 | Aboul-Hosn | Applicant |
| US6132363(A) | 2000-10-01 | Freed et al. | Applicant |
| US6135943(A) | 2000-10-01 | Yu et al. | Applicant |
| US6136025(A) | 2000-10-01 | Barbut et al. | Applicant |
| US6139487(A) | 2000-10-01 | Siess | Applicant |
| US6152704(A) | 2000-11-01 | Aboul-Hosn et al. | Applicant |
| US6162194(A) | 2000-12-01 | Shipp | Applicant |
| US6176822(B1) | 2001-01-01 | Nix et al. | Applicant |
| US6176848(B1) | 2001-01-01 | Rau et al. | Applicant |
| US6186665(B1) | 2001-02-01 | Maher et al. | Applicant |
| US6190304(B1) | 2001-02-01 | Downey et al. | Applicant |
| US6190357(B1) | 2001-02-01 | Ferrari et al. | Applicant |
| US6200260(B1) | 2001-03-01 | Bolling | Applicant |
| US6203528(B1) | 2001-03-01 | Deckert et al. | Applicant |
| US6210133(B1) | 2001-04-01 | Aboul-Hosn et al. | Applicant |
| US6210318(B1) | 2001-04-01 | Lederman | Applicant |
| US6210397(B1) | 2001-04-01 | Aboul-Hosn et al. | Applicant |
| US6214846(B1) | 2001-04-01 | Elliott | Applicant |
| US6217541(B1) | 2001-04-01 | Yu | Applicant |
| US6227797(B1) | 2001-05-01 | Watterson et al. | Applicant |
| US6234960(B1) | 2001-05-01 | Aboul-Hosn et al. | Applicant |
| US6234995(B1) | 2001-05-01 | Peacock, III | Applicant |
| US6245007(B1) | 2001-06-01 | Bedingham et al. | Applicant |
| US6245026(B1) | 2001-06-01 | Campbell et al. | Applicant |
| US6247892(B1) | 2001-06-01 | Kazatchkov et al. | Applicant |
| US6248091(B1) | 2001-06-01 | Voelker | Applicant |
| US6254359(B1) | 2001-07-01 | Aber | Applicant |
| US6254564(B1) | 2001-07-01 | Wilk et al. | Applicant |
| US6287319(B1) | 2001-09-01 | Aboul-Hosn | Applicant |
| US6287336(B1) | 2001-09-01 | Globerman et al. | Applicant |
| US6295877(B1) | 2001-10-01 | Aboul-Hosn et al. | Applicant |
| US6299635(B1) | 2001-10-01 | Frantzen | Applicant |
| US6305962(B1) | 2001-10-01 | Maher et al. | Applicant |
| US6387037(B1) | 2002-05-01 | Bolling et al. | Applicant |
| US6395026(B1) | 2002-05-01 | Aboul-Hosn et al. | Applicant |
| US6413222(B1) | 2002-07-01 | Pantages et al. | Applicant |
| US6422990(B1) | 2002-07-01 | Prem | Applicant |
| US6425007(B1) | 2002-07-01 | Messinger | Applicant |
| US6428464(B1) | 2002-08-01 | Bolling | Applicant |
| US6447266(B2) | 2002-09-01 | Antaki et al. | Applicant |
| US6454775(B1) | 2002-09-01 | Demarais et al. | Applicant |
| US6468298(B1) | 2002-10-01 | Pelton | Applicant |
| US6494694(B2) | 2002-12-01 | Lawless et al. | Applicant |
| US6503224(B1) | 2003-01-01 | Forman et al. | Applicant |
| US6508777(B1) | 2003-01-01 | MacOviak et al. | Applicant |
| US6508787(B2) | 2003-01-01 | Erbel Reimund et al. | Applicant |
| US6517315(B2) | 2003-02-01 | Belady | Applicant |
| US6517528(B1) | 2003-02-01 | Pantages et al. | Applicant |
| US6527699(B1) | 2003-03-01 | Goldowsky | Applicant |
| US6532964(B2) | 2003-03-01 | Aboul-Hosn et al. | Applicant |
| US6533716(B1) | 2003-03-01 | Schmitz-Rode et al. | Applicant |
| US6544216(B1) | 2003-04-01 | Sammler et al. | Applicant |
| US6547519(B2) | 2003-04-01 | DeBlanc et al. | Applicant |
| US6565598(B1) | 2003-05-01 | Lootz | Applicant |
| US6572349(B2) | 2003-06-01 | Sorensen et al. | Applicant |
| US6613008(B2) | 2003-09-01 | Aboul-Hosn et al. | Applicant |
| US6616323(B2) | 2003-09-01 | McGill | Applicant |
| US6623420(B2) | 2003-09-01 | Reich et al. | Applicant |
| US6623475(B1) | 2003-09-01 | Siess | Applicant |
| US6641093(B2) | 2003-11-01 | Coudrais | Applicant |
| US6641558(B1) | 2003-11-01 | Aboul-Hosn et al. | Applicant |
| US6645241(B1) | 2003-11-01 | Strecker | Applicant |
| US6673105(B1) | 2004-01-01 | Chen | Applicant |
| US6692318(B2) | 2004-02-01 | McBride | Applicant |
| US6709418(B1) | 2004-03-01 | Aboul-Hosn et al. | Applicant |
| US6716189(B1) | 2004-04-01 | Jarvik et al. | Applicant |
| US6749598(B1) | 2004-06-01 | Keren et al. | Applicant |
| US6776578(B2) | 2004-08-01 | Belady | Applicant |
| US6776794(B1) | 2004-08-01 | Hong et al. | Applicant |
| US6783328(B2) | 2004-08-01 | Lucke et al. | Applicant |
| US6790171(B1) | 2004-09-01 | Grundeman et al. | Applicant |
| US6794784(B2) | 2004-09-01 | Takahashi et al. | Applicant |
| US6794789(B2) | 2004-09-01 | Siess et al. | Applicant |
| US6817836(B2) | 2004-11-01 | Nose et al. | Applicant |
| US6818001(B2) | 2004-11-01 | Wulfman et al. | Applicant |
| US6835049(B2) | 2004-12-01 | Ray | Applicant |
| US6866625(B1) | 2005-03-01 | Ayre et al. | Applicant |
| US6866805(B2) | 2005-03-01 | Hong et al. | Applicant |
| US6887215(B2) | 2005-05-01 | McWeeney | Applicant |
| US6889082(B2) | 2005-05-01 | Bolling et al. | Applicant |
| US6926662(B1) | 2005-08-01 | Aboul-Hosn | Examiner |
| US6935344(B1) | 2005-08-01 | Aboul-Hosn et al. | Applicant |
| US6949066(B2) | 2005-09-01 | Bearnson et al. | Applicant |
| US6962488(B2) | 2005-11-01 | Davis et al. | Applicant |
| US6966748(B2) | 2005-11-01 | Woodard et al. | Applicant |
| US6972956(B2) | 2005-12-01 | Franz et al. | Applicant |
| US6974436(B1) | 2005-12-01 | Aboul-Hosn et al. | Applicant |
| US6981942(B2) | 2006-01-01 | Khaw et al. | Applicant |
| US6984392(B2) | 2006-01-01 | Bechert et al. | Applicant |
| US7010954(B2) | 2006-03-01 | Siess et al. | Applicant |
| US7011620(B1) | 2006-03-01 | Siess | Applicant |
| US7014417(B2) | 2006-03-01 | Salomon | Applicant |
| US7018182(B2) | 2006-03-01 | O'Mahony et al. | Applicant |
| US7022100(B1) | 2006-04-01 | Aboul-Hosn et al. | Applicant |
| US7122019(B1) | 2006-10-01 | Kesten et al. | Applicant |
| US7150711(B2) | 2006-12-01 | Nusser et al. | Applicant |
| US7160243(B2) | 2007-01-01 | Medvedev | Applicant |
| US7172551(B2) | 2007-02-01 | Leasure | Applicant |
| US7175588(B2) | 2007-02-01 | Morello | Applicant |
| US7214038(B2) | 2007-05-01 | Saxer et al. | Applicant |
| US7238010(B2) | 2007-07-01 | Hershberger et al. | Applicant |
| US7241257(B1) | 2007-07-01 | Ainsworth et al. | Applicant |
| US7284956(B2) | 2007-10-01 | Nose et al. | Applicant |
| US7288111(B1) | 2007-10-01 | Holloway et al. | Applicant |
| US7290929(B2) | 2007-11-01 | Smith et al. | Applicant |
| US7329236(B2) | 2008-02-01 | Kesten et al. | Applicant |
| US7381179(B2) | 2008-06-01 | Aboul-Hosn et al. | Applicant |
| US7478999(B2) | 2009-01-01 | Limoges | Applicant |
| US7491163(B2) | 2009-02-01 | Viole et al. | Applicant |
| US7534258(B2) | 2009-05-01 | Gomez et al. | Applicant |
| US7627667(B1) | 2009-12-01 | Rive et al. | Applicant |
| US7633193(B2) | 2009-12-01 | Masoudipour et al. | Applicant |
| US7645225(B2) | 2010-01-01 | Medvedev et al. | Applicant |
| US7682673(B2) | 2010-03-01 | Houston et al. | Applicant |
| US7722568(B2) | 2010-05-01 | Lenker et al. | Applicant |
| US7736296(B2) | 2010-06-01 | Siess et al. | Applicant |
| US7780628(B1) | 2010-08-01 | Keren et al. | Applicant |
| US7811279(B2) | 2010-10-01 | John | Applicant |
| US7878967(B1) | 2011-02-01 | Khanal | Applicant |
| US7918828(B2) | 2011-04-01 | Lundgaard et al. | Applicant |
| US7934912(B2) | 2011-05-01 | Voltenburg, Jr. et al. | Applicant |
| US7942844(B2) | 2011-05-01 | Moberg et al. | Applicant |
| US7955365(B2) | 2011-06-01 | Doty | Applicant |
| US7998190(B2) | 2011-08-01 | Gharib et al. | Applicant |
| US8025647(B2) | 2011-09-01 | Siess et al. | Applicant |
| US8052399(B2) | 2011-11-01 | Stemple et al. | Applicant |
| US8062008(B2) | 2011-11-01 | Voltenburg, Jr. et al. | Applicant |
| US8079948(B2) | 2011-12-01 | Shifflette | Applicant |
| US8114008(B2) | 2012-02-01 | Hidaka et al. | Applicant |
| US8123669(B2) | 2012-02-01 | Siess et al. | Applicant |
| US8142400(B2) | 2012-03-01 | Rotem et al. | Applicant |
| US8206350(B2) | 2012-06-01 | Mann et al. | Applicant |
| US8216122(B2) | 2012-07-01 | Kung et al. | Applicant |
| US8236040(B2) | 2012-08-01 | Mayberry et al. | Applicant |
| US8255050(B2) | 2012-08-01 | Mohl | Applicant |
| US8257312(B2) | 2012-09-01 | Duffy | Applicant |
| US8262619(B2) | 2012-09-01 | Chebator et al. | Applicant |
| US8277470(B2) | 2012-10-01 | Demarais et al. | Applicant |
| US8317715(B2) | 2012-11-01 | Belleville et al. | Applicant |
| US8333687(B2) | 2012-12-01 | Farnan et al. | Applicant |
| US8364278(B2) | 2013-01-01 | Pianca et al. | Applicant |
| US8388565(B2) | 2013-03-01 | Shifflette | Applicant |
| US8414845(B2) | 2013-04-01 | Chen et al. | Applicant |
| US8608635(B2) | 2013-12-01 | Yomtov et al. | Applicant |
| US8617239(B2) | 2013-12-01 | Reitan | Applicant |
| US8684904(B2) | 2014-04-01 | Campbell et al. | Applicant |
| US8690749(B1) | 2014-04-01 | Nunez | Applicant |
| US8721517(B2) | 2014-05-01 | Zeng et al. | Applicant |
| US8727959(B2) | 2014-05-01 | Reitan et al. | Applicant |
| US8784441(B2) | 2014-07-01 | Rosenbluth et al. | Applicant |
| US8790236(B2) | 2014-07-01 | Larose et al. | Applicant |
| US8795576(B2) | 2014-08-01 | Tao et al. | Applicant |
| US8801590(B2) | 2014-08-01 | Mohl | Applicant |
| US8814776(B2) | 2014-08-01 | Hastie et al. | Applicant |
| US8944748(B2) | 2015-02-01 | Liebing | Applicant |
| US8992406(B2) | 2015-03-01 | Corbett | Applicant |
| US8998792(B2) | 2015-04-01 | Scheckel | Applicant |
| US9028216(B2) | 2015-05-01 | Schumacher et al. | Applicant |
| US9089634(B2) | 2015-07-01 | Schumacher et al. | Applicant |
| US9089670(B2) | 2015-07-01 | Scheckel | Applicant |
| US9217442(B2) | 2015-12-01 | Wiessler et al. | Applicant |
| US9308302(B2) | 2016-04-01 | Zeng | Applicant |
| US9314558(B2) | 2016-04-01 | Er | Applicant |
| US9327067(B2) | 2016-05-01 | Zeng et al. | Applicant |
| US9328741(B2) | 2016-05-01 | Liebing | Applicant |
| US9358330(B2) | 2016-06-01 | Schumacher | Applicant |
| US2002/0010487(A1) | 2002-01-01 | Evans et al. | Applicant |
| US2002/0047435(A1) | 2002-04-01 | Takahashi et al. | Applicant |
| US2002/0094287(A1) | 2002-07-01 | Davis | Applicant |
| US2002/0107506(A1) | 2002-08-01 | McGuckin et al. | Applicant |
| US2002/0111663(A1) | 2002-08-01 | Dahl et al. | Applicant |
| US2002/0151761(A1) | 2002-10-01 | Viole et al. | Applicant |
| US2003/0018380(A1) | 2003-01-01 | Craig et al. | Applicant |
| US2003/0023201(A1) | 2003-01-01 | Aboul-Hosn et al. | Applicant |
| US2003/0100816(A1) | 2003-05-01 | Siess | Applicant |
| US2003/0135086(A1) | 2003-07-01 | Khaw et al. | Applicant |
| US2003/0187322(A1) | 2003-10-01 | Siess | Applicant |
| US2003/0205233(A1) | 2003-11-01 | Aboul-Hosn et al. | Applicant |
| US2003/0208097(A1) | 2003-11-01 | Aboul-Hosn et al. | Applicant |
| US2003/0228214(A1) | 2003-12-01 | McBride | Applicant |
| US2003/0231959(A1) | 2003-12-01 | Snider | Applicant |
| US2004/0010229(A1) | 2004-01-01 | Houde et al. | Applicant |
| US2004/0044266(A1) | 2004-03-01 | Siess et al. | Applicant |
| US2004/0101406(A1) | 2004-05-01 | Hoover | Applicant |
| US2004/0113502(A1) | 2004-06-01 | Li et al. | Applicant |
| US2004/0116862(A1) | 2004-06-01 | Ray | Applicant |
| US2004/0152944(A1) | 2004-08-01 | Medvedev et al. | Applicant |
| US2004/0253129(A1) | 2004-12-01 | Sorensen et al. | Applicant |
| US2005/0049696(A1) | 2005-03-01 | Siess et al. | Applicant |
| US2005/0085683(A1) | 2005-04-01 | Bolling et al. | Applicant |
| US2005/0090883(A1) | 2005-04-01 | Westlund et al. | Applicant |
| US2005/0095124(A1) | 2005-05-01 | Arnold et al. | Applicant |
| US2005/0113631(A1) | 2005-05-01 | Bolling et al. | Applicant |
| US2005/0135942(A1) | 2005-06-01 | Wood et al. | Applicant |
| US2005/0137680(A1) | 2005-06-01 | Ortiz et al. | Applicant |
| US2005/0165466(A1) | 2005-07-01 | Morris et al. | Applicant |
| US2005/0250975(A1) | 2005-11-01 | Carrier et al. | Applicant |
| US2005/0277912(A1) | 2005-12-01 | John | Applicant |
| US2006/0005886(A1) | 2006-01-01 | Parrino et al. | Applicant |
| US2006/0008349(A1) | 2006-01-01 | Khaw | Applicant |
| US2006/0036127(A1) | 2006-02-01 | Delgado, III et al. | Applicant |
| US2006/0058869(A1) | 2006-03-01 | Olson et al. | Applicant |
| US2006/0062672(A1) | 2006-03-01 | McBride et al. | Applicant |
| US2006/0063965(A1) | 2006-03-01 | Aboul-Hosn et al. | Applicant |
| US2006/0089521(A1) | 2006-04-01 | Chang | Applicant |
| US2006/0155158(A1) | 2006-07-01 | Aboul-Hosn | Applicant |
| US2006/0167404(A1) | 2006-07-01 | Pirovano et al. | Applicant |
| US2007/0142785(A1) | 2007-06-01 | Lundgaard et al. | Applicant |
| US2007/0156006(A1) | 2007-07-01 | Smith et al. | Applicant |
| US2007/0203442(A1) | 2007-08-01 | Bechert et al. | Applicant |
| US2007/0212240(A1) | 2007-09-01 | Voyeux et al. | Applicant |
| US2007/0217932(A1) | 2007-09-01 | Voyeux et al. | Applicant |
| US2007/0217933(A1) | 2007-09-01 | Haser et al. | Applicant |
| US2007/0233270(A1) | 2007-10-01 | Weber et al. | Applicant |
| US2007/0237739(A1) | 2007-10-01 | Doty | Applicant |
| US2007/0248477(A1) | 2007-10-01 | Nazarifar et al. | Applicant |
| US2008/0004645(A1) | 2008-01-01 | To et al. | Applicant |
| US2008/0004690(A1) | 2008-01-01 | Robaina | Applicant |
| US2008/0031953(A1) | 2008-02-01 | Takakusagi et al. | Applicant |
| US2008/0103516(A1) | 2008-05-01 | Wulfman et al. | Applicant |
| US2008/0103591(A1) | 2008-05-01 | Siess | Applicant |
| US2008/0114339(A1) | 2008-05-01 | McBride et al. | Applicant |
| US2008/0119943(A1) | 2008-05-01 | Armstrong et al. | Applicant |
| US2008/0132748(A1) | 2008-06-01 | Shifflette | Applicant |
| US2008/0167679(A1) | 2008-07-01 | Papp | Applicant |
| US2008/0168796(A1) | 2008-07-01 | Masoudipour et al. | Applicant |
| US2008/0306327(A1) | 2008-12-01 | Shifflette | Applicant |
| US2009/0018567(A1) | 2009-01-01 | Escudero et al. | Applicant |
| US2009/0023975(A1) | 2009-01-01 | Marseille et al. | Applicant |
| US2009/0024085(A1) | 2009-01-01 | To et al. | Applicant |
| US2009/0053085(A1) | 2009-02-01 | Thompson et al. | Applicant |
| US2009/0062597(A1) | 2009-03-01 | Shifflette | Applicant |
| US2009/0073037(A1) | 2009-03-01 | Penna et al. | Applicant |
| US2009/0087325(A1) | 2009-04-01 | Voltenburg, Jr. et al. | Applicant |
| US2009/0093764(A1) | 2009-04-01 | Pfeffer et al. | Applicant |
| US2009/0093765(A1) | 2009-04-01 | Glenn | Applicant |
| US2009/0093796(A1) | 2009-04-01 | Pfeffer et al. | Applicant |
| US2009/0099638(A1) | 2009-04-01 | Grewe | Applicant |
| US2009/0112312(A1) | 2009-04-01 | Larose et al. | Applicant |
| US2009/0118567(A1) | 2009-05-01 | Siess | Applicant |
| US2009/0163864(A1) | 2009-06-01 | Breznock et al. | Applicant |
| US2009/0171137(A1) | 2009-07-01 | Farnan et al. | Applicant |
| US2009/0182188(A1) | 2009-07-01 | Marseille et al. | Applicant |
| US2009/0234378(A1) | 2009-09-01 | Escudero et al. | Applicant |
| US2010/0030161(A1) | 2010-02-01 | Duffy | Applicant |
| US2010/0030186(A1) | 2010-02-01 | Stivland | Applicant |
| US2010/0041939(A1) | 2010-02-01 | Siess | Applicant |
| US2010/0047099(A1) | 2010-02-01 | Miyazaki et al. | Applicant |
| US2010/0087773(A1) | 2010-04-01 | Ferrari | Applicant |
| US2010/0094089(A1) | 2010-04-01 | Litscher et al. | Applicant |
| US2010/0127871(A1) | 2010-05-01 | Pontin | Applicant |
| US2010/0137802(A1) | 2010-06-01 | Yodfat et al. | Applicant |
| US2010/0174239(A1) | 2010-07-01 | Yodfat et al. | Applicant |
| US2010/0191035(A1) | 2010-07-01 | Kang et al. | Applicant |
| US2010/0197994(A1) | 2010-08-01 | Mehmanesh | Applicant |
| US2010/0268017(A1) | 2010-10-01 | Siess | Applicant |
| US2010/0274330(A1) | 2010-10-01 | Burwell et al. | Applicant |
| US2010/0286210(A1) | 2010-11-01 | Murata et al. | Applicant |
| US2010/0286791(A1) | 2010-11-01 | Goldsmith | Applicant |
| US2011/0004046(A1) | 2011-01-01 | Campbell et al. | Applicant |
| US2011/0004291(A1) | 2011-01-01 | Davis et al. | Applicant |
| US2011/0009687(A1) | 2011-01-01 | Mohl | Applicant |
| US2011/0015610(A1) | 2011-01-01 | Plahey et al. | Applicant |
| US2011/0034874(A1) | 2011-02-01 | Reitan et al. | Applicant |
| US2011/0076439(A1) | 2011-03-01 | Zeilon | Applicant |
| US2011/0098805(A1) | 2011-04-01 | Dwork et al. | Applicant |
| US2011/0106004(A1) | 2011-05-01 | Eubanks et al. | Applicant |
| US2011/0152831(A1) | 2011-06-01 | Rotem et al. | Applicant |
| US2011/0152906(A1) | 2011-06-01 | Escudero et al. | Applicant |
| US2011/0152907(A1) | 2011-06-01 | Escudero et al. | Applicant |
| US2011/0218516(A1) | 2011-09-01 | Grigorov | Applicant |
| US2011/0237863(A1) | 2011-09-01 | Ricci et al. | Applicant |
| US2011/0257462(A1) | 2011-10-01 | Rodefeld et al. | Applicant |
| US2011/0270182(A1) | 2011-11-01 | Breznock et al. | Applicant |
| US2011/0275884(A1) | 2011-11-01 | Scheckel | Applicant |
| US2011/0300010(A1) | 2011-12-01 | Jarnagin et al. | Applicant |
| US2012/0029265(A1) | 2012-02-01 | Larose et al. | Applicant |
| US2012/0059213(A1) | 2012-03-01 | Spence et al. | Applicant |
| US2012/0059460(A1) | 2012-03-01 | Reitan | Applicant |
| US2012/0083740(A1) | 2012-04-01 | Chebator et al. | Applicant |
| US2012/0142994(A1) | 2012-06-01 | Toellner | Applicant |
| US2012/0172654(A1) | 2012-07-01 | Bates | Applicant |
| US2012/0172655(A1) | 2012-07-01 | Campbell et al. | Applicant |
| US2012/0172656(A1) | 2012-07-01 | Walters et al. | Applicant |
| US2012/0178985(A1) | 2012-07-01 | Walters et al. | Applicant |
| US2012/0178986(A1) | 2012-07-01 | Campbell et al. | Applicant |
| US2012/0184803(A1) | 2012-07-01 | Simon et al. | Applicant |
| US2012/0220854(A1) | 2012-08-01 | Messerly et al. | Applicant |
| US2012/0224970(A1) | 2012-09-01 | Schumacher et al. | Applicant |
| US2012/0226097(A1) | 2012-09-01 | Smith et al. | Applicant |
| US2012/0234411(A1) | 2012-09-01 | Scheckel | Applicant |
| US2012/0237357(A1) | 2012-09-01 | Schumacher et al. | Applicant |
| US2012/0265002(A1) | 2012-10-01 | Roehn et al. | Applicant |
| US2013/0041202(A1) | 2013-02-01 | Toellner et al. | Applicant |
| US2013/0053622(A1) | 2013-02-01 | Corbett | Applicant |
| US2013/0053623(A1) | 2013-02-01 | Evans et al. | Applicant |
| US2013/0066140(A1) | 2013-03-01 | McBride et al. | Applicant |
| US2013/0085318(A1) | 2013-04-01 | Toellner | Applicant |
| US2013/0085319(A1) | 2013-04-01 | Evans et al. | Applicant |
| US2013/0096364(A1) | 2013-04-01 | Reichenbach et al. | Applicant |
| US2013/0103063(A1) | 2013-04-01 | Escudero et al. | Applicant |
| US2013/0106212(A1) | 2013-05-01 | Nakazumi et al. | Applicant |
| US2013/0138205(A1) | 2013-05-01 | Kushwaha et al. | Applicant |
| US2013/0204362(A1) | 2013-08-01 | Toellner et al. | Applicant |
| US2013/0209292(A1) | 2013-08-01 | Baykut et al. | Applicant |
| US2013/0237744(A1) | 2013-09-01 | Pfeffer et al. | Applicant |
| US2013/0245360(A1) | 2013-09-01 | Schumacher | Applicant |
| US2013/0303831(A1) | 2013-11-01 | Evans et al. | Applicant |
| US2013/0303969(A1) | 2013-11-01 | Keenan et al. | Applicant |
| US2013/0303970(A1) | 2013-11-01 | Keenan et al. | Applicant |
| US2013/0331639(A1) | 2013-12-01 | Campbell et al. | Applicant |
| US2013/0345492(A1) | 2013-12-01 | Pfeffer et al. | Applicant |
| US2014/0005467(A1) | 2014-01-01 | Farnan et al. | Applicant |
| US2014/0010686(A1) | 2014-01-01 | Tanner et al. | Applicant |
| US2014/0012065(A1) | 2014-01-01 | Fitzgerald et al. | Applicant |
| US2014/0039465(A1) | 2014-02-01 | Schulz et al. | Applicant |
| US2014/0051908(A1) | 2014-02-01 | Khanal et al. | Applicant |
| US2014/0067057(A1) | 2014-03-01 | Callaway et al. | Applicant |
| US2014/0088455(A1) | 2014-03-01 | Christensen et al. | Applicant |
| US2014/0128659(A1) | 2014-05-01 | Heuring et al. | Applicant |
| US2014/0148638(A1) | 2014-05-01 | Larose et al. | Applicant |
| US2014/0163664(A1) | 2014-06-01 | Goldsmith | Applicant |
| US2014/0255176(A1) | 2014-09-01 | Bredenbreuker et al. | Applicant |
| US2014/0275725(A1) | 2014-09-01 | Schenck et al. | Applicant |
| US2014/0275726(A1) | 2014-09-01 | Zeng | Applicant |
| US2014/0301822(A1) | 2014-10-01 | Scheckel | Applicant |
| US2014/0303596(A1) | 2014-10-01 | Schumacher et al. | Applicant |
| US2015/0025558(A1) | 2015-01-01 | Wulfman et al. | Applicant |
| US2015/0031936(A1) | 2015-01-01 | Larose et al. | Applicant |
| US2015/0051435(A1) | 2015-02-01 | Siess et al. | Applicant |
| US2015/0051436(A1) | 2015-02-01 | Spanier et al. | Applicant |
| US2015/0080743(A1) | 2015-03-01 | Siess et al. | Applicant |
| US2015/0087890(A1) | 2015-03-01 | Spanier et al. | Applicant |
| US2015/0141738(A1) | 2015-05-01 | Toellner et al. | Applicant |
| US2015/0141739(A1) | 2015-05-01 | Hsu et al. | Applicant |
| US2015/0151032(A1) | 2015-06-01 | Voskoboynikov et al. | Applicant |
| US2015/0209498(A1) | 2015-07-01 | Franano et al. | Applicant |
| US2015/0250935(A1) | 2015-09-01 | Anderson et al. | Applicant |
| US2015/0290372(A1) | 2015-10-01 | Muller et al. | Applicant |
| US2015/0343179(A1) | 2015-12-01 | Schumacher et al. | Applicant |
| US2016/0184500(A1) | 2016-06-01 | Zeng | Applicant |
| US2016/0250399(A1) | 2016-09-01 | Tiller et al. | Applicant |
| US2016/0250400(A1) | 2016-09-01 | Schumacher | Applicant |
| US2016/0256620(A1) | 2016-09-01 | Scheckel et al. | Applicant |
| CA2701810(A1) | 2009-04-01 | Applicant | |
| EP453234(A1) | 1991-10-01 | Applicant | |
| EP533432(A1) | 1993-03-01 | Applicant | |
| EP1393762(A1) | 2004-03-01 | Applicant | |
| EP1591079(A1) | 2005-11-01 | Applicant | |
| EP2298374(A1) | 2011-03-01 | Applicant | |
| FR2267800(A1) | 1975-11-01 | Applicant | |
| GB2239675(A) | 1991-07-01 | Applicant | |
| JPS4823295(U) | 1973-03-01 | Applicant | |
| JPS58190448(A) | 1983-11-01 | Applicant | |
| JPH02211169(A) | 1990-08-01 | Applicant | |
| JPH06114101(A) | 1994-04-01 | Applicant | |
| JPH08196624(A) | 1996-08-01 | Applicant | |
| JPH1099447(A) | 1998-04-01 | Applicant | |
| JP3208454(B2) | 2001-09-01 | Applicant | |
| TW500877(B) | 2002-09-01 | Applicant | |
| WO9526695(A2) | 1995-10-01 | Applicant | |
| WO9715228(A1) | 1997-05-01 | Applicant | |
| WO19097(A1) | 2000-04-01 | Applicant | |
| WO43062(A1) | 2000-07-01 | Applicant | |
| WO69489(A1) | 2000-11-01 | Applicant | |
| WO124867(A1) | 2001-04-01 | Applicant | |
| WO2070039(A2) | 2002-09-01 | Applicant | |
| WO3103745(A2) | 2003-12-01 | Applicant | |
| WO2005089674(A1) | 2005-09-01 | Applicant | |
| WO2005123158(A1) | 2005-12-01 | Applicant | |
| WO2009073037(A1) | 2009-06-01 | Applicant | |
| WO2009076460(A2) | 2009-06-01 | Applicant | |
| WO2010133567(A1) | 2010-11-01 | Applicant | |
| WO2010149393(A1) | 2010-12-01 | Applicant | |
| WO2011035926(A1) | 2011-03-01 | Applicant | |
| WO2011035929(A2) | 2011-03-01 | Applicant | |
| WO2011039091(A1) | 2011-04-01 | Applicant | |
| WO2011076439(A1) | 2011-06-01 | Applicant | |
| WO2011089022(A1) | 2011-07-01 | Applicant | |
| WO2012007140(A1) | 2012-01-01 | Applicant | |
| WO2012007141(A1) | 2012-01-01 | Applicant | |
| WO2013148697(A1) | 2013-10-01 | Applicant | |
| WO2013160407(A1) | 2013-10-01 | Applicant | |
| WO2014019274(A1) | 2014-02-01 | Applicant | |
| WO2015063277(A2) | 2015-05-01 | Applicant |
Non-Patent Literature (50)
- Abiomed, “Impella 5.0 with the Impella Console, Circulatory Support System, Instructions for Use & Clinical Reference Manual,” Jun. 2010, in 122 pages.Applicant
- Abiomed—Recovering Hearts. Saving Lives., Impella 2.5 System, Instructions for Use, Jul. 2007, in 86 sheets.Applicant
- Aboul-Hosn et al., “The Hemopump: Clinical Results and Future Applications”, Assisted Circulation 4, 1995, in 14 pages.Applicant
- Barras et al., “Nitinol-Its Use in Vascular Surgery and Other Applications,” Eur. J. Vasc. Endovasc. Surg., 2000, pp. 564-569; vol. 19.Applicant
- Biscarini et al., “Enhanced Nitinol Properties for Biomedical Applications,” Recent Patents on Biomedical Engineering, 2008, pp. 180-196, vol. 1(3).Applicant
- Cardiovascular Diseases (CVDs) Fact Sheet No. 317; World Health Organization [Online], Sep. 2011. http://www.who.int/mediacentre/factsheets/fs317/en/index.html, accessed on Aug. 29, 2012.Applicant
- Compendium of Technical and Scientific Information for the HEMOPUMP Temporary Cardiac Assist System, Johnson & Johnson Interventional Systems, 1988, in 15 pages.Applicant
- Dekker et al., “Efficacy of a New Intraaortic Propeller Pump vs the Intraaortic Balloon Pump*, An Animal Study”, Chest, Jun. 2003, vol. 123, No. 6, pp. 2089-2095.Applicant
- Duerig et al., “An Overview of Nitinol Medical Applications,” Materials Science Engineering, 1999, pp. 149-160; vol. A273.Applicant
- European Search Report received in European Patent Application No. 05799883.3, dated May 10, 2011, in 4 pages.Applicant
- Extended European Search Report received in European Patent Application No. 07753903.9, dated Oct. 8, 2012, in 7 pages.Applicant
- Extended European Search Report received in European Patent Application No. 13790890.1, dated Jan. 7, 2016, in 6 pages.Applicant
- Extended European Search Report received in European Patent Application No. 13791118.6, dated Jan. 7, 2016, in 6 pages.Applicant
- Extended European Search Report received in European Patent Application No. 13813687.4, dated Feb. 24, 2016, in 6 pages.Applicant
- Extended European Search Report received in European Patent Application No. 13813867.2, dated Feb. 26, 2016, in 6 pages.Applicant
- Extended European Search Report received in European Patent Application No. 14779928.2, dated Oct. 7, 2016, in 6 pages.Applicant
- Extended European Search Report received in European Patent Application No. 14764392.8, dated Oct. 27, 2016, in 7 pages.Applicant
- Federal and Drug Administration 510(k) Summary for Predicate Device Impella 2.5 (K112892), prepared Sep. 5, 2012.Applicant
- Grech, “Percutaneous Coronary Intervention. I: History and Development,” BMJ., May 17, 2003, pp. 1080-1082, vol. 326.Applicant
- Hsu et al., “Review of Recent Patents on Foldable Ventricular Assist Devices,” Recent Patents on Biomedical Engineering, 2012, pp. 208-222, vol. 5.Applicant
- Ide et al., “Evaluation of the Pulsatility of a New Pulsatile Left Ventricular Assist Device—the Integrated Cardioassist Catheter-in Dogs,” J. of Thorac and Cardiovasc Sur, Feb. 1994, pp. 569-0575, vol. 107(2).Applicant
- Ide et al., “Hemodynamic Evaluation of a New Left Ventricular Assist Device: An Integrated Cardioassist Catheter as a Pulsatile Left Ventricle-Femoral Artery Bypass,” Blackwell Scientific Publications, Inc., 1992, pp. 286-290, vol. 16(3).Applicant
- Impella CP® —Instructions for Use & Clinical Reference Manual (United States only), Abiomed, Inc., Jul. 2014, 148 pages, www.abiomed.com.Applicant
- Impella LD® with the Impella® Controller—Circulatory Support System—Instructions for Use & Clinical Reference Manual (United States only), Abiomed, Inc., Sep. 2010, 132 pages, www.abiomed.com.Applicant
- International Preliminary Examination Report received in International Patent Application No. PCT/US2003/04853, dated Jul. 26, 2004, in 5 pages.Applicant
- International Preliminary Examination Report received in International Patent Application No. PCT/US2003/04401, dated May 18, 2004, in 4 pages.Applicant
- International Preliminary Report on Patentability and Written Opinion of the International Searching Authority received in International Patent Application No. PCT/US2005/033416, dated Mar. 20, 2007, in 7 pages.Applicant
- International Preliminary Report on Patentability and Written Opinion of the International Searching Authority received in International Patent Application No. PCT/US2007/007313, dated Sep. 23, 2008, in 6 pages.Applicant
- International Preliminary Report on Patentability and Written Opinion received in International Patent Application No. PCT/US2014/020878, dated Sep. 15, 2015, in 8 pages.Applicant
- International Search Report and Written Opinion received in International Patent Application No. PCT/US2005/033416, dated Dec. 11, 2006, in 8 pages.Applicant
- International Search Report and Written Opinion received in International Patent Application No. PCT/US2007/007313, dated Mar. 4, 2008, in 6 pages.Applicant
- International Search Report and Written Opinion received in International Patent Application No. PCT/US2012/020382, dated Jul. 31, 2012, in 11 pages.Applicant
- International Search Report and Written Opinion received in International Patent Application No. PCT/US2012/020369, dated Jul. 30, 2012, in 10 pages.Applicant
- International Search Report and Written Opinion received in International Patent Application No. PCT/US2012/020553, dated Aug. 17, 2012, in 8 pages.Applicant
- International Search Report and Written Opinion received in International Patent Application No. PCT/US2012/020383, dated Aug. 17, 2012; in 9 pages.Applicant
- International Search Report and Written Opinion received in International Patent Application No. PCT/US2013/040798, dated Aug. 21, 2013, in 16 pages.Applicant
- International Search Report and Written Opinion received in International Patent Application No. PCT/US2013/040799, dated Aug. 21, 2013, in 19 pages.Applicant
- International Search Report and Written Opinion received in International Patent Application No. PCT/US2013/040809, dated Sep. 2, 2013, in 25 pages.Applicant
- International Search Report and Written Opinion received in International Patent Application No. PCT/US2013/048332, dated Oct. 16, 2013, in 17 pages.Applicant
- International Search Report and Written Opinion received in International Patent Application No. PCT/US2013/048343, dated Oct. 11, 2013, in 15 pages.Applicant
- International Search Report and Written Opinion received in International Patent Application No. PCT/US2014/020878, dated May 7, 2014, in 13 pages.Applicant
- International Search Reort and Written Opinion received in International Patent Application No. PCT/US2015/026013, dated Jul. 8, 2015, in 12 pages.Applicant
- International Search Report and Written Opinion received in International Patent Application No. PCT/US2015/026014, dated Jul. 15, 2015, in 13 pages.Applicant
- International Search Report and Written Opinion received in International Patent Application No. PCT/US2015/026025, dated Jul. 20, 2015, in 12 pages.Applicant
- International Search Report and Written Opinion received in International Patent Application No. PCT/US2015/025959, dated Aug. 28, 2015, in 16 pages.Applicant
- International Search Report and Written Opinion received in International Patent Application No. PCT/US2015/025960, dated Sep. 3, 2015, in 15 pages.Applicant
- International Search Report and Written Opinion received in International Patent Application No. PCT/US2015/045370, dated Nov. 18, 2015, in 12 pages.Applicant
- International Search Report and Written Opinion received in International Patent Application No. PCT/US2016/014371, dated May 2, 2016, in 18 pages.Applicant
- International Search Report and Written Opinion received in International Patent Application No. PCT/US2016/014379, dated Jul. 25, 2016, in 19 pages.Applicant
- International Search Report and Written Opinion received in International Patent Application No. PCT/US2016/014391, dated May 2, 2016, in 17 pages.Applicant